Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2022 Mar 11;18(3):e1010103. doi: 10.1371/journal.pgen.1010103

Box C/D small nucleolar ribonucleoproteins regulate mitochondrial surveillance and innate immunity

Elissa Tjahjono 1, Alexey V Revtovich 1, Natalia V Kirienko 1,*
Editor: Javier E Irazoqui2
PMCID: PMC8942280  PMID: 35275914

Abstract

Monitoring mitochondrial function is crucial for organismal survival. This task is performed by mitochondrial surveillance or quality control pathways, which are activated by signals originating from mitochondria and relayed to the nucleus (retrograde response) to start transcription of protective genes. In Caenorhabditis elegans, several systems are known to play this role, including the UPRmt, MAPKmt, and the ESRE pathways. These pathways are highly conserved and their loss compromises survival following mitochondrial stress. In this study, we found a novel interaction between the box C/D snoRNA core proteins (snoRNPs) and mitochondrial surveillance and innate immune pathways. We showed that box C/D, but not box H/ACA, snoRNPs are required for the full function of UPRmt and ESRE upon stress. The loss of box C/D snoRNPs reduced mitochondrial mass, mitochondrial membrane potential, and oxygen consumption rate, indicating overall degradation of mitochondrial function. Concomitantly, the loss of C/D snoRNPs increased immune response and reduced host intestinal colonization by infectious bacteria, improving host resistance to pathogenesis. Our data may indicate a model wherein box C/D snoRNP machinery regulates a “switch” of the cell’s activity between mitochondrial surveillance and innate immune activation. Understanding this mechanism is likely to be important for understanding multifactorial processes, including responses to infection and aging.

Author summary

Mitochondrial health is important for organismal survival. Multiple cellular pathways are dedicated to actively monitoring mitochondrial status, termed as the mitochondrial surveillance system, to provide better defense towards variety of stresses. These systems are highly conserved and present in both C. elegans and humans. Here we report that the Box C/D snoRNA core proteins (snoRNPs), normally associated with modification of ribosomal RNA, play a role in mitochondrial surveillance and innate immune pathways. The loss of this protein complex reduced mitochondrial surveillance pathway activation after stress but increased immune responses. As mitochondrial surveillance, innate immunity, and box C/D snoRNP pathways are conserved in humans, understanding their roles in modulating cell biology during mitochondrial crises is essential for mitigating stress and restoring health after damage.

Introduction

All living organisms require the maintenance of cellular homeostasis under conditions very different than their surroundings. Maintaining these conditions requires constant surveillance for disruption and metabolic adjustments to reacquire the proper biochemical balance. Meanwhile, a variety of insults can disrupt this balance, ranging from environmental changes to metabolic dysfunction to pathogen infection. Indeed, almost all cellular pathways are disrupted in one infection or another, including protein translation [1,2], the proteostatic machinery [35], the cytoskeleton [6], the endoplasmic reticulum [7,8], and others [9,10].

Given the central role of mitochondria in energy production, biosynthesis of heme groups, lipid metabolism, the regulation of iron and calcium homeostasis, and production of reactive oxygen species (ROS), it should be no surprise that mitochondria are impacted by disease and infection [1113]. Consequently, they are subjected to several important surveillance pathways. The two best known are the PINK1/Parkin axis for macroautophagic mitochondrial recycling (commonly known as mitophagy) and the unfolded protein response in mitochondria (UPRmt) [1417]. Both systems monitor the functionality of mitochondrial protein import and they have been thoroughly investigated in various model organisms, including C. elegans, yeast, and mice. For example, in the former pathway, accumulation of the kinase PINK1 on the outer mitochondrial surface licenses its ability to phosphorylate its targets, including Parkin, resulting in the subsequent recruitment of autophagic machinery. Under similar conditions of compromised mitochondrial import, the key transcription factor ATFS-1/ATF5 is redirected from mitochondria, where it would be degraded, to the nucleus, where it regulates the expression of chaperones and other stress mediators.

A third, rather more elusive, mitochondrial pathway utilizes the DLK-1/SEK-3/PMK-3 MAP kinase cascade (which we will refer to as the MAPKmt pathway) and was identified in C. elegans by activating mitochondrial stress and searching for differentially expressed genes that were independent of ATFS-1/ATF5 [18]. Regulation of this pathway appears to involve a C/EBP family transcription factor called CBP-3 and disrupted mitochondrial electron transport chain (ETC) function. The MAPKmt pathway is involved in the extended lifespan observed in long-lived mitochondrial (Mit) mutants [18]. Interestingly, fluvastatin, which disrupts mevalonate metabolism and prevents geranylgeranylation of certain components of the vesicular trafficking system, also activates the MAPKmt pathway, indicating that surveillance of mitochondrial cholesterol metabolism is also important [19].

Our lab has previously identified a key mitochondrial surveillance program in C. elegans regulated by cellular ROS [20,21]. This pathway, known as the Ethanol and Stress Response (ESRE) network, is named for an 11-nucleotide motif found in the promoter region of hundreds of genes in C. elegans and ethanol-responsive genes in mice, and is activated by a range of abiotic triggers [2224]. Interestingly, exposure to the opportunistic human pathogen, Pseudomonas aeruginosa, which produces a xenobiotic siderophore called pyoverdine that hijacks mitochondria-resident iron from C. elegans, also activates the ESRE network [20,25,26]. This also appears to be the first known stress pathway to respond to intracellular reductive stress [21].

Active study from our lab and others has linked several determinants to ESRE gene expression, including the JumonjiC-domain containing protein JMJC-1/Riox1 (also known as NO66) [22], the PBAF nucleosome remodeling complex [27], a family of bZIP transcription factors (ZIP-2, ZIP-4, CEBP-1, and CEBP-2) [20], and the Zn-finger transcription factor SLR-2 [22,28]. Importantly, the ESRE motif, the genes regulated by it, and their activation in response to stress are ancient and evolutionarily conserved from C. elegans to humans [22,24].

Mitochondrial surveillance programs not only activate programs to reacquire homeostasis, they also regulate innate immune functions [25,2932], a process sometimes termed surveillance immunity [33]. However, innate immune activation is energetically costly and requires considerable energy conversion [34,35] and excess immune activity is associated with a broad range of deleterious health outcomes. Thus, it behooves the organism to carefully balance its need to reacquire homeostasis and repair damage against stimulating innate immune functions that can cause further damage. How organisms navigate this choice remains a poorly understood area of biology.

Small nucleolar ribonucleoproteins (snoRNPs) are small complexes of RNA and protein best known for catalyzing site-directed modifications to RNA. snoRNPs fall into two major groups, called the box C/D and box H/ACA families, that are categorized based on their functions and the secondary structures of their snoRNA components [36]. Box C/D snoRNPs, consisting of FIB-1/Fibrillarin (the catalytic methyltransferase), NOL-56/Nop56, NOL-58/Nop58, and M28.5/SNU13 (Fig 1A, left), perform 2’-O-methylation, while box H/ACA snoRNPs, comprised of Y66H1A.4/Gar1, Y48A6B.3/Nhp2, NOLA-3/Nop10, and K01G5.5/dyskerin, convert targeted uridine residues to pseudouridine (Fig 1A, right) [37]. Both families mainly target ribosomal RNA, with the modifications typically clustered at biologically important locations [38]. The snoRNA in each complex confers the targeting function via sequence complementarity to the modification target site; it helps to orient and target the enzymatic function of the snoRNP complex [38]. snoRNP complexes have been suggested to have functional roles well beyond the processing of rRNA, including 2′-O-methylation, splicing, and translation of mRNAs [3943].

Fig 1. Box C/D snoRNP machinery binds to the ESRE motif.

Fig 1

(A) Cartoon representation of box C/D (left) or box H/ACA (right) snoRNA-snoRNP complexes. Stars indicate proteins identified through oligo pulldown-mass spectrometry. (B) Electrophoretic mobility shift assay (EMSA) showed the presence of the ESRE-binding motif through the identified ‘Shift’. (C) Quantification of GFP fluorescence of C. elegans carrying a 3XESRE::GFP reporter that was reared on E. coli expressing RNAi targeting empty vector (EV) or fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi). (D) The size and (E) lifespan of glp-4(bn2) worms grown on RNAi strains targeting Box C/D snoRNPs are shown. (F) Fluorescent images (left) and quantification of GFP fluorescence (right) of C. elegans carrying a 3XESRE::GFP reporter reared on E. coli expressing RNAi targeting empty vector (EV), fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi). (G) Upregulation of ESRE gene transcripts as measured via qRT-PCR. Worms were reared on E. coli expressing RNAi targeting empty vector (EV) or fib-1(RNAi) and were treated with DMSO or 25 μM rotenone for 8 hours. RNAi treatment was started at the L1 (C) or L3 (D-G) stage. Representative images are shown. Three biological replicates comprised of ~400 (C, D, F), ~150 (E), or ~8,000 (G) worms/replicate were analyzed. A representative replicate for the lifespan assay is shown (E). (C, F) Worms were treated for 8 hours with vehicle (DMSO) or 50 μM rotenone and GFP values were normalized to EV-DMSO. Worms’ sizes were normalized to EV control. p values were determined from two-way or one-way ANOVA for ESRE expression and worms’ size measurement, respectively, followed by Dunnett’s test, log-rank test for lifespan assay, or Student’s t-test for qRT-PCR. NS not significant, * p < 0.05, ** p < 0.01, *** p < 0.001. In panels with colored significance marks, purple indicates comparison between gene(RNAi) and EV(RNAi) in control condition (DMSO), red indicates comparison between gene(RNAi) and EV(RNAi) in stressed condition (rotenone), and black indicates comparison between stressed and control conditions.

In this study, we identified a non-canonical role for the box C/D snoRNP complex, which appears to serve as a molecular switch that activates mitochondrial surveillance and represses conventional innate immune processes. Specifically, box C/D snoRNPs upregulate ESRE and UPRmt while downregulating the function of the PMK-1/p38 MAPK pathway. Contrarily, knockdown of box C/D snoRNPs upregulated MAPKmt pathway effectors, but this was likely a secondary effect from the loss of MAPKmt repression by the UPRmt, which is characteristic of the complicated interactions between these surveillance systems. Since box C/D snoRNPs and these mitochondrial surveillance systems are conserved between C. elegans and humans, our results may lead to a better understanding of processes that affect mitochondrial health and innate immune pathways in human diseases.

Results

Identification of FIB-1/Fibrillarin and NOL-56/Nop56 as regulators of the ESRE pathway

To identify additional regulatory components of the ESRE pathway, a biotinylated oligonucleotide comprised of a 4x tandem repeat of the consensus 11-nucleotide ESRE motif was used as bait for biochemical pulldown. Young adult C. elegans were exposed to either DMSO, 1 mM phenanthroline (a chemical iron chelator), or 50 μM rotenone (an inhibitor of ETC Complex I) to trigger mitochondrial damage and ESRE gene activation [20]. Proteins were extracted from the cytoplasm and nuclei and mixed with the biotinylated ESRE bait and then pulled down using streptavidin-coated magnetic beads. An electrophoretic mobility shift assay (EMSA) [27] was used to optimize enrichment of ESRE-binding proteins and to verify specificity (Fig 1B).

We detected multiple bands from the EMSA, labeled as ‘Shift’ and ‘Free probes’ (Fig 1B). The ‘Free probes’ are excess biotinylated ESRE oligos that did not bind protein. Multiple ‘Shift‘ bands were observed, which may indicate constitutive binding of the ESRE motif or a different activated form of the transcription factor [44]. These bands were thicker upon treatment with phenanthroline or rotenone, indicating an increase in DNA-binding activity (Fig 1B). An EMSA experiment was also performed using mutated ESRE sites (three mutations per element) to confirm specificity. These substitutions considerably reduced binding by material from rotenone-treated worms compared to wild-type ESRE (S1 Fig). These results confirmed that one or more stress-inducible nuclear factor(s) bind the ESRE motif after mitochondrial damage and suggested that it may be required for the transcription of the ESRE genes. Materials bound under these conditions were eluted and subjected to tandem MS/MS analysis for identification of potential peptide fragments.

The gene products identified by mass spectrometry were categorized by using the ‘SRA’ binning system and the ‘iBAQ’ score. The ‘SRA’ or ‘Strict, Relaxed, and All’ binning approach utilizes tiered metrics to score gene identification quality, in which the identified ‘Strict’ genes products pass a 1% FDR cutoff [45]. Meanwhile, the ‘iBAQ’ scores were calculated based on peptide peak intensities and number of potential peptides, comparable to the absolute protein quantity. By searching for proteins that passed the ‘SRA’ binning system as ‘Strict’ and that are enriched in rotenone-treated samples compared to DMSO control, 75 candidate proteins were identified (S1 Table).

To establish a role in ESRE function, each gene predicted to encode one of these proteins was knocked down via RNAi in a strain of C. elegans carrying an ESRE-GFP transcriptional reporter (3x tandem repeat of the ESRE consensus sequence driving a GFP reporter, 3xESRE,GFP) [21]. After knockdown, activation of the reporter was induced using 50 μM rotenone. Amongst the candidate genes, only RNAi targeting fib-1/Fibrillarin and nol-56/Nop56 reduced reporter expression (Fig 1C). As NOL-58 is a third member of the box C/D snoRNP complex (Fig 1A) but was not identified in the affinity-purified material, nol-58/Nop58(RNAi) was tested for the ability to reduce ESRE-GFP expression. Like its other box C/D snoRNP counterparts, RNAi targeting nol-58/Nop58 reduced ESRE expression (Fig 1C). The current model of box C/D snoRNP assembly suggests that FIB-1/Fibrillarin and NOL-58/Nop58 independently bind to the snoRNA and then NOL-56/Nop56 associates with the complex, but does not bind to the snoRNA alone [46]. Since knockdown of any of the genes for these three proteins reduced ESRE signaling, it seems likely that the snoRNP complex as a whole is binding to ESRE.

Although worms reared on RNAi targeting fib-1/FBL, nol-56/Nop56, or nol-58/Nop58 exhibited reductions in ESRE signaling, they also showed clear signs of reduced growth and development, giving rise to smaller adults, which is consistent with a previous report [47]. To reduce the possibility that our observations were due to non-specific developmental effects, we tested the impact of disrupting snoRNP targets after the L3 stage. Beginning RNAi at this developmental stage eliminated overt effects on final length of the worms (Fig 1D), except when M28.5(RNAi) was used. As such, M28.5(RNAi) was excluded from further experiments. Starting RNAi at L3 not only mitigated the negative impact that snoRNP RNAi had on C. elegans lifespan (Fig 1E and S2 Table), but also extended lifespan for fib-1(RNAi) (similar to what was observed in [41]), suggesting overall increased health.

Exposure at a later stage of development can circumvent some of the developmental effects and apparent general malaise, but it can also reduce the penetrance of the RNAi phenotype [48]. In this case, however, snoRNP knockdown at L3 stage still reduced ESRE activation upon stress (Fig 1F). We also quantified gene transcripts in worms reared on E. coli expressing empty vector (EV) or fib-1(RNAi). Expression of ESRE genes in fib-1(RNAi) worms in response to rotenone was reduced compared to controls (Fig 1G). These data confirm that regulation of ESRE pathway by box C/D snoRNPs is specific and differs from their requirement during early developmental stages for overall C. elegans health.

Box C/D snoRNPs also regulate UPRmt and MAPKmt

To assess whether knocking down box C/D snoRNPs only affected the ESRE pathway or also impacted other mitochondrial stress responses, we triggered activation of downstream effectors for UPRmt and MAPKmt using RNAi targeting the mitochondria-resident protease SPG-7/AFG3L2 (spg-7/SPG7(RNAi)), which efficiently induces UPRmt [18,29,49]. Young adult worms carrying GFP reporters for the UPRmt (Phsp-6::GFP) or MAPKmt (Ptbb-6::GFP) surveillance pathways were reared on plates containing all pairwise mixtures of RNAi: empty vector or spg-7/SPG7(RNAi) with empty vector, fib-1(RNAi), nol-56(RNAi) or nol-58(RNAi). As with the ESRE pathway, knockdown of fib-1, nol-56, or nol-58 reduced the ability of the UPRmt to respond to stress, regardless of whether RNAi was begun at the L1 or L3 stage (Fig 2A and 2B). Unlike the ESRE pathway however, we also observed significant reduction of the basal reporter gene expression following L1 RNAi (Fig 2A). Moreover, neither condition completely disrupted UPRmt activity (compare Figs 1C and 2A).

Fig 2. Box C/D snoRNP knockdown reduces UPRmt but increased MAPKmt expression.

Fig 2

(A-D) Fluorescent images (left) and quantification of GFP fluorescence (right) of C. elegans carrying Phsp-6::GFP (A, B) or Ptbb-6::GFP (C, D) reporters reared on E. coli expressing empty vector (EV), fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi). Each RNAi construct was paired with either empty vector (EV) or spg-7(RNAi). RNAi treatment was started at L1 (A, C) or L3 (B, D) stage. Representative images are shown; three biological replicates with ~400 worms/replicate were analyzed. p values were determined from two-way ANOVA, followed by Dunnett’s test, or Student’s t-test. All fold changes were normalized to EV control. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In all panels, purple significance marks indicate comparison between gene(RNAi) and EV(RNAi) in unstressed condition, red marks indicate comparison between gene(RNAi) and EV(RNAi) in stressed condition (spg-7(RNAi)), and black marks indicate comparison between stressed and unstressed conditions.

Contrary to what was observed for UPRmt, fib-1(RNAi), nol-56(RNAi), and nol-58(RNAi) significantly increased basal expression level of the Ptbb-6::GFP MAPKmt reporter (Fig 2C), indicating that the box C/D snoRNP complex is directly or indirectly involved in repressing its basal expression. This difference disappeared if RNAi targeting the box C/D snoRNP complex was initiated at the L3 stage (Fig 2D). RNAi at either stage had no effect on Ptbb-6::GFP expression after spg-7(RNAi)-mediated induction.

Previously, we demonstrated relationships between the ESRE network and the UPRmt and MAPKmt pathways [21]. For example, UPRmt or MAPKmt activity normally places a brake on the ESRE network by limiting the production of ESRE-activating ROS. We also identified an ESRE motif in the promoter region of atfs-1/ATF5 that was required for its full expression. Previously, we used CRISPR to generate a mutant strain where the ESRE site in the promoter region of the atfs-1 gene was completely removed [21]. This strain was crossed with the UPRmt reporter Phsp-6::GFP reporter and then self-crossed to ensure homozygosity of the ESRE deletion. The resulting strain was used to evaluate the importance of the ESRE site in regulation of hsp-6.

We used spg-7(RNAi) to induce Phsp-6::GFP reporter expression in strains with or without the ESRE motif present in the atfs-1 promoter reared on vector control or after disrupting the box C/D snoRNP complex. As expected, spg-7(RNAi) induced GFP expression in each condition. Similar to our previous findings, basal and induced expression of Phsp-6::GFP was reduced in the absence of the ESRE motif from atfs-1/ATF5 (blue stars in Fig 3A (for RNAi starting at L1) and 3B (for RNAi starting at L3)). Adding RNAi targeting the box C/D machinery to the ESRE deletion changed basal expression (purple significance marks, compared to basal EV(RNAi)) only when RNAi was initiated at L1 stage (Fig 3A). Induction of hsp-6::GFP by spg-7(RNAi) was lower when compared to empty vector (red stars) or when compared to induced conditions with an intact promoter and box C/D RNAi (blue stars) (Fig 3A and 3B). These data indicate that the box C/D complex regulates UPRmt both via modulation of the ESRE pathway (due to the ESRE motif, which is required for full expression of atfs-1) and independently of ESRE.

Fig 3. Disruption of box C/D snoRNPs affects UPRmt and MAPKmt expression through the ESRE motif.

Fig 3

(A-B) Images and (A-D) quantification of GFP fluorescence of C. elegans carrying Phsp-6::GFP (A, B) or Ptbb-6::GFP (C, D) reporters that were reared on E. coli expressing empty vector (EV) or RNAi targeting fib-1/FBL, nol-56/Nop56, or nol-58/Nop58. (A, B) Phsp-6::GFP reporter strains were wild-type or crossed with Patfs-1ΔESRE::ATFS-1WT. RNAi was paired with empty vector (EV) or spg-7(RNAi) (A, B), pmk-3(RNAi) (C), or atfs-1(RNAi) (D). Three biological replicates with ~400 worms/replicate were analyzed. (A, B) Representative images are shown on the left. p-values were determined from two-way ANOVA, followed by Dunnett’s test, or Student’s t-test. All fold changes were normalized to EV control. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In all panels, purple significance marks indicate comparison between gene(RNAi) and EV(RNAi) in unstressed condition, red marks indicate comparison between gene(RNAi) and EV(RNAi) in stressed condition (spg-7(RNAi)), and black marks indicate comparison between stressed and unstressed conditions. Additionally, blue significance marks indicate comparison between Phsp-6::GFP expression in Patfs-1ΔESRE::ATFS-1WT and wild-type backgrounds.

Meanwhile, Ptbb-6::GFP expression was at least partially dependent upon PMK-3/MAPK14, as expected, both under wild-type and box C/D snoRNP RNAi conditions (Fig 3C). Previously we demonstrated that ATFS-1 plays a role in repressing tbb-6 expression [21]. Since we showed above that ATFS-1 activity depends on box C/D snoRNPs, we tested whether fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi) would affect ATFS-1-mediated repression of tbb-6. In each case, atfs-1 knockdown was indistinguishable from atfs-1; snoRNP double RNAi (Fig 3D). Combined, these data argue that the box C/D complex regulates basal expression of the MAPKmt stress response system, possibly by altering levels of ATFS-1. We also speculate that the absence of changes for basal ESRE reporter expression are due to consistent observations that ESRE network activation must be spurred by recognition of stress, while Phsp-6::GFP and Ptbb-6::GFP exhibit low levels of expression even in the absence of stress [18].

To ensure that the simultaneous use of two RNAi targets did not reduce their independent knockdown efficiency, several supplemental experiments were performed. First, empty vector controls were substituted with an RNAi construct targeting luciferase. As none of the strains in use encode luciferase, expression of this RNAi construct will engage the RNAi machinery, but should not have any other biological effect. As expected, no observable difference was seen in expression of the 3xESRE::GFP, Phsp-6::GFP, or Ptbb-6::GFP reporters when the luciferase construct was substituted for the empty vector, either alone or in combination with RNAi targeting other genes (S2A and S2B Fig). Additionally, fib-1 and spg-7 transcripts were quantified via qRT-PCR when they were knocked down either alone or in combination with luciferase RNAi (S2C and S2D Fig).

We further asked whether localization of these snoRNPs in the nucleolus was necessary for regulation. We knocked down ruvb-1/RUVB, an AAA+ ATPase that promotes box C/D snoRNP assembly and localization to nucleoli [47]. Although worms reared on ruvb-1(RNAi)-expressing E. coli at L1 did not show growth arrest, ruvb-1/RUVB(RNAi) markedly reduced ESRE expression following stress (S3A Fig). However, induced expression of UPRmt was not affected (S3B Fig) and increased in basal expression of MAPKmt reporter was also more modest than what was observed for C/D snoRNP knockdown (S3C Fig). This suggests that localization of box C/D snoRNPs may affect some but not all the responses of mitochondrial surveillance.

ruvb-1/RUVB(RNAi) in a worm strain carrying an endogenously expressed, GFP-tagged FIB-1 (Pfib-1::FIB-1::eGFP) was tested to determine the expression and localization of FIB-1/FBL. Knockdown of fib-1/FBL starting at L1 or L3 significantly reduced FIB-1 fluorescence intensity (S3D Fig). Similarly, ruvb-1/RUVB(RNAi) significantly reduced FIB-1/FBL fluorescence, but to a lesser extent than fib-1 knockdown (S3D Fig). This is consistent with our observation that ESRE expression was reduced more in fib-1(RNAi) compared to ruvb-1(RNAi). Interestingly, we also observed that Pfib-1::FIB-1::eGFP punctae increased in size after treatment with the mitochondrial poisons CCCP or rotenone (Fig 4A and 4B). In contrast, treatment with cycloheximide (a translational inhibitor) and tunicamycin (an ER stress inducer) reduced the size of Pfib-1::FIB-1::eGFP punctae (Fig 4A and 4B). This shows that FIB-1/FBL fluorescence is altered under ESRE-activating conditions and may indicate that mitochondrial damage changes either the expression level of the gene or alters the subcellular localization of the protein product.

Fig 4. Mitochondrial disruption increases the size of Pfib-1::FIB-1::eGFP fluorescent punctae.

Fig 4

(A) Images and (B) quantification of FIB-1::eGFP in worms treated for 4 hours with vehicle (DMSO), 10 μM CCCP, 50 μM rotenone, 2 mg/mL cycloheximide, or 60 μM tunicamycin. Three biological replicates with ~25 worms/replicate were analyzed. p-values were determined from one-way ANOVA, followed by Dunnett’s test. *** p < 0.001.

Disruption of box H/ACA snoRNP machinery does not affect mitochondrial surveillance pathways

One possible explanation for the phenomena that we observed was that the reduction of 2’-O-methylation of rRNA compromised normal ribosomal function, and that this reduced ESRE gene expression. If this were the case, other broad-scale ribosomal changes should have similar outcomes. For example, disrupting box H/ACA-mediated conversion of dozens to hundreds of uridine residues to pseudouridine in rRNA [50,51] should have a very similar effect. In contrast to box C/D snoRNP genes, RNAi targeting nola-3/Nop10, Y48A6B.3/Nhp2, or Y66H1A.4/Gar1 showed no significant change for any of the mitochondrial surveillance pathways tested, whether under basal or mitochondrial stress-induced conditions (S4 Fig). This result indicates that the function of box C/D snoRNPs in regulating mitochondrial homeostasis is specific. It also suggests that wide-scale disruption of the ribosome is unlikely to be the cause of diminished ESRE activation. mRNA levels were quantified using qRT-PCR to ensure that RNAi treatment had the intended effect (S5 Fig).

Suppressing translation does not recapitulate changes in mitochondrial surveillance caused by disrupting the box C/D snoRNP complex

2’-O-methylation has a number of effects on ribosome maturation and stability. One possible consequence of disrupting ribosomal biology is a global reduction in translation [52,53]. Translation efficiency is known to be a target of surveillance in C. elegans, as shown by increased expression of the immune response gene irg-1 after exposure to exotoxin A, hygromycin, or cycloheximide [1,2]. Recently it was shown that fib-1/FBL knockdown also activates irg-1 [42]. We recapitulated these data and observed increased Pirg-1::GFP reporter expression on fib-1(RNAi), nol-56(RNAi) or nol-58(RNAi) as well as after treatment with cycloheximide (S6 Fig). Consequently, Tiku et al, hypothesized that innate immune activation was an indirect event, caused by a diminished translation as a result of fibrillarin disruption and compromised ribosomal function [42]. We set out to explore whether the decreased levels of the ESRE reporter following fib-1(RNAi) are caused by the same mechanism.

We used RNAi to target the genes encoding components of the eukaryotic 48S transcription initiation complex, including clu-1/eIF3A, inf-1/eIF4A, ife-2/eIF4E, ifg-1/eIF4G, and T12D8.2/eIF4H. Since RNAi targeting ifg-1/eIF4G and inf-1/eIF4A compromised development when RNAi was started at the L1 stage, subsequent experiments were performed by feeding RNAi starting at the L3 stage of development. Expression of reporters for the mitochondrial surveillance pathways being tested was not consistently affected by disrupting the 48S complex (Fig 5), with the exception of inf-1/eIF4A(RNAi), which reduced rotenone-mediated ESRE activation and spg-7(RNAi)-mediated UPRmt activation, and increased basal expression of MAPKmt. However, induction of the Phsp-6::GFP reporter by spg-7(RNAi) was also significantly decreased for clu-1/eIF3A(RNAi), ifg-1/eIF4G(RNAi), and ife-2/eIF4E(RNAi), suggesting some specialized interactions (Fig 5B).

Fig 5. Blocking translational initiation generally does not diminish activation of mitochondrial surveillance pathways.

Fig 5

Quantification of GFP fluorescence of C. elegans carrying 3XESRE::GFP (A), Phsp-6::GFP (B), or Ptbb-6::GFP (C) reporters that were reared on E. coli expressing empty vector (EV) or RNAi targeting the eukaryotic initiation factors clu-1/eIF3A, ife-2/eIF4E, ifg-1/eIF4G, inf-1/eIF4A, or T12D8.2/eIF4H. (A) Worms were treated for 8 hours with vehicle (DMSO) or 50 μM rotenone. (B, C) Worms were stressed with spg-7(RNAi), and an empty vector (EV) control was included. Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from two-way ANOVA, followed by Dunnett’s test, or Student’s t-test. All fold changes were normalized to DMSO-EV or EV control. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In all panels, purple significance marks indicate comparison between gene(RNAi) and EV(RNAi) in unstressed condition (DMSO or EV(RNAi)), red marks indicate comparison between gene(RNAi) and EV(RNAi) in stressed condition (rotenone or spg-7(RNAi)), and black marks indicate comparison between stressed and unstressed conditions.

As a final test, we treated reporter worms for each of the three mitochondrial surveillance pathways with the chemical translational inhibitor cycloheximide. Under conditions where irg-1 activation was observed (indicating successful disruption of translation, see S6B Fig), cycloheximide exposure had no effect on ESRE or MAPKmt reporter expression (S7 Fig). These results further indicated that general translational reduction is unlikely to be the mechanism underlying box C/D snoRNP regulation of the ESRE mitochondrial surveillance network.

Box C/D snoRNPs repress innate immune responses

As mentioned above, fibrillarin knockdown has previously been linked to increased pathogen resistance [42], and we and others observed increased expression of Pirg-1::GFP, an immune reporter, in fib-1(RNAi) worms. To test whether disruption of the box C/D snoRNP complex induced other cellular defense pathways, we monitored the expression of Pirg-5::GFP reporter, which is activated by a number of pathogens and xenobiotics [54,55] and is relatively insensitive to translational inhibition (Fig 6A and [2]).

Fig 6. Knockdown of box C/D snoRNPs increases immune activation.

Fig 6

Quantification of GFP fluorescence of C. elegans carrying Pirg-5::GFP (A-C) or PT24B8.5::GFP (D) reporter. (A) Worms were treated for 8 hours with vehicle (DMSO) or translation elongation inhibitor cycloheximide (2 mg/mL). (B-D) Worms were reared on E. coli expressing empty vector (EV), fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi). Young adult worms were transferred onto plates containing E. coli or P. aeruginosa for 8 hours before imaging. RNAi treatment was started at the L1 (B) or L3 (C, D) stage. Representative images are shown on the left for unstressed conditions (C, D). (E) Fold-upregulation of immune genes under the regulation of both UPRmt and p38 MAPK pathways (dark blue) or genes under the control of other regulatory pathways (light blue) in wild-type worms reared on fib-1(RNAi) from the L3 stage. Three biological replicates with ~400 (A-D) or ~8,000 (E) worms/replicate. p-values were determined from two-way ANOVA, followed by Dunnett’s test, or Student’s t-test for GFP quantification assays, or one-way ANOVA, followed by Dunnett’s test for qRT-PCR. All fold-changes were normalized to EV control on E. coli. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In panels with multi-colored significance marks, purple indicates comparison between gene(RNAi) and EV(RNAi) in the control condition (E. coli), red indicates comparison between gene(RNAi) and EV(RNAi) after exposure to P. aeruginosa, and black indicates comparison between stressed and control conditions.

Worms carrying the Pirg-5::GFP reporter were reared on either empty vector or RNAi targeting components of the box C/D snoRNP complex, and then GFP expression was evaluated in young adults. Interestingly, this disruption activated irg-5 more strongly than P. aeruginosa infection on agar in empty vector controls (Fig 6B). It is also worth noting that infecting worms with fib-1(RNAi) or nol-58(RNAi) with P. aeruginosa did not further increase GFP expression compared to uninfected counterparts, suggesting that irg-5 induction may have already been maximized.

As we had previously observed, box C/D RNAi might affect pathway induction differently when RNAi was started at L1 vs L3. Specifically, increased irg-5 basal induction was much stronger when RNAi feeding was initiated at the L1 stage (Fig 6B and 6C). This observation is also consistent with our interpretation that Pirg-5::GFP expression is nearly saturated when box C/D is knocked down early in development (Fig 6B). These results indicate that early developmental C/D snoRNP complexes are required for appropriate innate immune function later in development.

Recently, Campos et al. established a link between mild mitochondrial impairment and enhanced immunity [32]. In their report, regulation of several immune genes was dependent on both the UPRmt and the PMK-1/p38 immune pathways. To address this possibility, we tested whether the loss of box C/D snoRNPs affected expression of p38 MAPK immune effectors. First, expression of the PT24B8.5::GFP reporter strain was tested after box C/D RNAi by exposing the worms to E. coli or P. aeruginosa. T24B8.5 is an innate immune effector gene under the control of both PMK-1 and the UPRmt. Under these conditions, we saw that box C/D RNAi activated innate immune pathways on normal laboratory food for the host, but did not drive it to higher levels than exposure to a pathogen (Fig 6D). A wider range of immune effectors were also assessed via qRT-PCR after fib-1(RNAi) and were shown to also be significantly upregulated (Fig 6E). This result strongly argues that the loss of box C/D snoRNPs causes a broad-spectrum increase in innate immune activation.

As irg-5 was not significantly upregulated by translational repression, snoRNPs are likely to affect innate immune pathways via multiple mechanisms. irg-5 is known to be controlled by several transcriptional regulators, including PMK-1/p38 MAPK and ATF-7/ATF7 [55], both of which are established regulators of innate immunity in C. elegans [56]. ATF-7/ATF7 functions downstream of PMK-1/p38 MAPK, but it can regulate irg-5 activation independently of PMK-1/p38 MAPK. NHR-86/HNF4 also regulates irg-5 expression, specifically in response to the small molecule immune stimulant RPW-24 [57]. To determine whether any of these transcriptional regulators were involved in box C/D regulation of innate immunity, we compared Pirg-5::GFP expression in worms with double RNAi targeting fib-1/Fibrillarin, nol-56/Nop56, or nol-58/Nop58 and pmk-1/p38 MAPK, atf-7/ATF7, or nhr-86/HNF4.

Both pmk-1(RNAi) (Fig 7A) and atf-7(RNAi) (Fig 7B) reduced Pirg-5::GFP expression, with the latter virtually abolishing reporter fluorescence. nhr-86(RNAi) (Fig 7C) had no apparent effect. These data suggest that the effects of the box C/D snoRNP complex on irg-5 are upstream of its known regulation by the transcription factor ATF-7/ATF7. However, atf-7(RNAi) did not affect expression of irg-1, an immune effector whose basal expression was also upregulated upon box C/D snoRNP knockdown (Fig 7D). This suggests that box C/D snoRNPs exhibit complex modulation of innate immune pathways. We verified this result using qRT-PCR to measure several effectors dependent upon PMK-1 and ATF-7 in pmk-1(km25) and atf-7(gk715) mutants reared on fib-1(RNAi). Generally, fib-1(RNAi)-induced expression of these immune genes were dramatically reduced in both mutants, although irg-1 was an exception (Fig 7E). Notably, the pmk-1(km25) mutant also completely abolished expression of irg-5, likely due to a complete loss of PMK-1 in the mutant.

Fig 7. ATF-7 and PMK-1 partially mediate immune responses induced by the loss of C/D snoRNPs but do not affect mitochondrial surveillance pathways.

Fig 7

(A-C) Innate immune activation was quantified by measuring GFP expression in Pirg-1::GFP worms reared on empty vector (EV), fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi) in all pair-wise combinations with empty vector (EV) (A-C), pmk-1(RNAi) (A), atf-7(RNAi) (B), or nhr-86(RNAi) (C). (D) Innate immune activation was quantified by measuring GFP expression in Pirg-1::GFP worms reared on the following RNAi combinations: EV; EV, atf-7; EV, EV; fib-1, or atf-7; fib-1. (E) Expression of the innate immune genes irg-1, irg-5, K08D8.5, T24B8.5, and Y9C9A.8 was measured via qRT-PCR in wild-type (N2), atf-7(gk715), or pmk-1(km25) mutants reared on empty vector or fib-1(RNAi). Gene expression was compared to empty vector controls. (F,G) GFP fluorescence was quantified in worms carrying 3XESRE::GFP (F) or Ptbb-6::GFP (G) reporters reared on EV; EV, atf-7(RNAi); EV, EV; fib-1(RNAi), or atf-7(RNAi); fib-1(RNAi). In (F), worms were exposed to either DMSO (control) or 50 μM rotenone for 8 hours prior to imaging. RNAi treatment was started at the L1 stage (A-C, G) or L3 stage (D-F). Three biological replicates with ~400 (GFP quantification) or ~8,000 (qRT-PCR) worms/replicate were used. p-values were determined from two-way ANOVA, followed by Dunnett’s test, or Student’s t-test for GFP quantification assay, or one-way ANOVA, followed by Dunnett’s test for qRT-PCR data. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In panels with multi-colored significance marks, purple indicates comparison between gene(RNAi) and EV(RNAi) in control (EV(RNAi) (A-C) or DMSO (F)) conditions. Red indicates comparison between gene(RNAi) and EV(RNAi) in pmk-1(RNAi) (A), atf-7(RNAi) (B), nhr-86(RNAi) (C), or rotenone (F). Black indicates comparison between pmk-1(RNAi) (A), atf-7(RNAi) (B), nhr-86(RNAi) (C), or rotenone (F) to untreated controls in the same panel. Blue indicates comparison between atf-7(RNAi);fib-1(RNAi) and EV;fib-1(RNAi) after rotenone treatment (F).

This led us to question whether ATF-7 is involved in the regulation of other reporters that are differentially expressed under box C/D disruption. To test the 3XESRE::GFP reporter, worms were reared on combinations of empty vector, fib-1(RNAi), atf-7(RNAi), or both starting at the L3 stage. Young adults were then exposed to rotenone and reporter induction was measured. Knockdown of atf-7 was indistinguishable from vector control (red “NS” mark). atf-7(RNAi); fib-1(RNAi) showed no apparent difference from just fib-1(RNAi) (blue “NS” mark) (Fig 7F). This indicates that the box C/D regulation of ESRE is independent of ATF-7 and is different from the regulation of irg-5.

We also tested whether the increase in basal expression of Ptbb-6::GFP after fib-1(RNAi) was related to ATF-7 by rearing the reporter on fib-1(RNAi) alone or with atf-7(RNAi) starting at the L1 larval stage. As expected, basal levels of the reporter were increased after fib-1(RNAi) but not by atf-7(RNAi) alone (Fig 7G). However, we did observe an additive effect on Ptbb-6::GFP in atf-7(RNAi);fib-1(RNAi), suggesting that the two genes work together to limit inappropriate expression of the MAPKmt pathway.

Although our previous experiments had ruled out a role for box H/ACA snoRNPs in the regulation of mitochondrial surveillance (S4 Fig), we wanted to investigate their role in innate immunity. A knockdown of box H/ACA did not invoke any response from the immune genes irg-1 and irg-5 (S8 Fig), confirming the specificity of box C/D snoRNPs.

Box C/D snoRNPs provide protection against mitochondrial damage from pathogens

To test whether the loss of box C/D snoRNPs had physiologically relevant consequences, we performed P. aeruginosa Liquid Killing (liquid pathogenesis) and Slow Killing (agar pathogenesis) assays to measure survival. Although both assays use the same pathogen, the virulence and pathogenic mechanisms and the host defenses differ. In the Liquid Killing assay, host death occurs due to the production of the siderophore pyoverdine, which is secreted by the bacterium to obtain iron [26,58]. Pyoverdine enters host tissue and removes iron from mitochondria, causing sufficient damage to inflict death [59,60]. This damage also activates the ESRE mitochondrial surveillance network, which is important for host defense [20].

The Slow Killing assay involves a more traditional form of bacterial pathogenesis, where the host intestine is colonized by the pathogen. Killing involves quorum sensing, although the precise cause of death has not yet been determined [61,62]. Slow Killing activates the conventional NSY-1/SEK-1/PMK-1 MAPK pathway, which is the most common antibacterial defense in C. elegans [6365]. Interestingly, there appears to be little overlap between the two defense networks, as there is no activation of ESRE during Slow Killing and PMK-1 activity is detrimental for survival in Liquid Killing conditions [25,66].

Worms were reared on RNAi targeting fib-1/Fibrillarin, nol-56/Nop56, or nol-58/Nop58 from the L3 larval stage, and then young adults were exposed to P. aeruginosa strain PA14 either under Liquid Killing or Slow Killing conditions. As anticipated based on the role of ESRE in improving survival in Liquid Killing and the observation that box C/D snoRNP knockdown compromises ESRE function, removal of box C/D function strongly reduced host survival in Liquid Killing (Fig 8A). Interestingly, we saw the opposite in Slow Killing, where box C/D snoRNP RNAi slightly, but statistically significantly, increased host survival (Fig 8B and S3 Table). This is consistent with a prior report that FIB-1 reduces host survival during infection [42]. We also quantified intestinal colonization in this model and observed significantly lower colonization of the worms’ intestines when box C/D snoRNP complexes were disrupted (Fig 8C).

Fig 8. Box C/D snoRNP disruption has context-specific effects on P. aeruginosa pathogenesis.

Fig 8

(A, B) Survival of glp-4(bn2) worms grown on box C/D(RNAi) (A) Liquid Killing (LK, liquid pathogenesis model) and (B) Slow killing (SK, agar pathogenesis model) assays. (C) Quantification of colony forming units (CFU) within the intestine of glp-4(bn2) worms grown on box C/D(RNAi) 48 hours post infection with P. aeruginosa in the SK assay. (D) Survival of N2 wild-type, atf-7(gk715), or pmk-1(km25) mutant worms reared on empty vector (EV) or fib-1(RNAi). (E, F) Quantification of fluorescence of worms carrying a Pfib-1::FIB-1::eGFP reporter 10 hours after exposure to P. aeruginosa in Liquid Killing (LK, (E)) or Slow Killing (SK, (F)) pathogenesis models. Three biological replicates with ~400 (LK), ~150 worms/replicate (SK), or ~60 (CFU assay and FIB-1::eGFP imaging) worms/replicate were analyzed. Representative replicates are shown for the SK assays. p-values were determined from one-way ANOVA, followed by Dunnett’s test for LK or CFU assay, log-rank test for SK, or Student’s t-test for FIB-1::eGFP imaging data. *p < 0.05, ** p < 0.01, *** p < 0.001. (D) Purple significance marks indicate comparison between atf-7(gk715) or pmk-1(km25) mutants and wild-type (N2) worms reared on empty vector RNAi (EV), red marks indicate comparison between atf-7(gk715) and pmk-1(km25) mutants to wild-type (N2) worms reared on fib-1(RNAi), and black marks indicate comparison between fib-1(RNAi) and EV(RNAi) for each worm strain.

Next, the effect of ATF-7 and PMK-1 on increased survival in Slow Killing by box C/D RNAi was assessed. Slow Killing assays were performed with wild-type, atf-7(gk715), and pmk-1(km25) mutant worms reared on empty vector or box C/D RNAi. Interestingly, the loss of box C/D snoRNPs increased survival of atf-7(gk715) and pmk-1(km25) mutants, as was observed for wild-type worms (Figs 8D and S9 and S4 Table). These results were not entirely unexpected, considering that there are multiple immune pathways in the host and some innate immune genes are outside of the control of the MAPK pathway [67,68]. Together, these results strengthen our hypothesis that the loss of box C/D snoRNPs increased host immune responses.

Interestingly, Liquid Killing also increased the size of FIB-1::eGFP punctae (Fig 8E), reinforcing the conclusion above that the change in FIB-1::GFP patterns may result from mitochondrial damage. In contrast, infection with P. aeruginosa in the agar pathogenesis model (Slow Killing) reduced FIB-1::GFP punctae size (Fig 8F). This is consistent with a previous report that bacterial infection reduced both FIB-1 level and nucleolar size [42].

Box C/D snoRNP support normal mitochondrial function

To assess the importance of the box C/D snoRNPs in mitochondrial function more directly, we measured mitochondrial membrane potential, mitochondrial mass, and oxygen consumption rate in wild-type worms reared on E. coli carrying either an empty vector control or RNAi targeting box C/D snoRNPs. Mitochondrial membrane potential was measured using MitoTracker Red, a dye that accumulates in mitochondria in a membrane-potential-dependent fashion. Mitochondrial mass was measured using MitoTracker Green, a dye that is comparatively insensitive to membrane potential. Oxygen consumption rate was measured using a biological oxygen monitor with a Clark-type oxygen electrode. Consistent with our hypothesis, we observed reduction in all three parameters after box C/D snoRNP disruption (Fig 9A–D). It is worth noting that the decrease in mitochondrial membrane potential and oxygen consumption rate was proportional to the decrease in mitochondrial mass (Fig 9E and 9F). These data further strengthen our conclusion that disruption of box C/D snoRNPs dysregulates mitochondrial surveillance pathways and compromises normal mitochondrial biology.

Fig 9. The loss of box C/D snoRNPs reduced mitochondrial health and function.

Fig 9

Measurement of (A) mitochondrial mass, (B) mitochondrial membrane potential, and (C-D) oxygen consumption rate of wild-type (N2) worms reared on E. coli expressing RNAi targeting empty vector (EV) or the box C/D snoRNP machinery (fib-1/FBL, nol-56/Nop56, or nol-58/Nop58). Mitochondrial parameters were measured on basal levels (A-C) or after 8 hours treatment with 25 μM rotenone or DMSO control (D). (E) Mitochondrial membrane potential or (F) oxygen consumption rate was normalized to mitochondrial mass. Three biological replicates with ~400 (mitochondrial mass and membrane potential measurements) or 6,000 (oxygen consumption rate measurements) worms/replicate were analyzed. p values were determined from one-way or two-way ANOVA, followed by Dunnett’s test. *p < 0.05, ** p < 0.01, *** p < 0.001. (D) Purple significance marks indicate comparison between fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi) and EV(RNAi) in DMSO, red significance marks indicate comparison between fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi) and EV(RNAi) in rotenone.

Discussion

In this study, we identified a role for the box C/D snoRNP complex in regulating the switch between mitochondrial surveillance and innate immunity. Using biochemical approaches, we made the unexpected discovery that FIB-1/Fibrillarin and NOL-56/Nop56 were associated with a tandem repeat of the ESRE motif. This is unexpected for two reasons. First, the RNA sequences for which box C/D snoRNAs are named, the C (RUGAUGA) and D (CUGA) boxes, have been well-studied and bear very little sequence similarity to the ESRE motif (TCTGCGTCTCT). Although these are all consensus sequences and have some variability, they have essentially no match, making it seem quite unlikely that the proteins are recognizing the ESRE site directly. Second, as noted above, the association of NOL-56/Nop56 with the box C/D snoRNP complex is based on protein-protein interactions, suggesting that the interaction with the ESRE bait is likely to involve the entire snoRNA complex.

Interestingly, the interactions between box C/D snoRNPs and mitochondrial surveillance pathways are specific. RNAi of box C/D starting at L3 stage results in decreased expression of reporters for ESRE and UPRmt, while expression of MAPKmt is not affected. Importantly, knockdown of gene expression at this stage does not decrease worm size or shorten lifespan, suggesting that the health of the worms is not seriously compromised. This indicates that the reduction in ESRE or UPRmt signaling is not an artifact of reduced reporter expression due to worm malaise. Instead, the interaction is likely to be specific. This is further validated by our observations that reducing ESRE expression via box C/D RNAi in the context of Liquid Killing shortens lifespan and that box C/D RNAi disrupts mitochondrial function.

There are some caveats to our use of RNAi in this study of the role of box C/D snoRNPs. First, RNAi exhibits different efficacy in knockdown from gene-to-gene, making it possible that different members of the complex may be differently affected [69]. RNAi also occasionally yields different phenotypes than mutants [70]. For example, box C/D snoRNP RNAi induces irg-5 immune gene expression. Both pmk-1(RNAi) and the pmk-1(km25) mutant have reduced irg-5 expression in this case, but the mutants had a greater impact. Despite these caveats, our findings support the conclusions that we have drawn.

Box C/D snoRNPs have recently been linked to an increasing variety of function beyond their canonical role in rRNA methylation, including rare cases of guiding RNA editing [71], tRNA methylation [72], and even association with mRNA (including an ‘orphan’ snoRNA with no known rRNA target that destabilizes several mRNAs) [73,74]. Given recent observations that snoRNAs are more frequently found in the cytoplasm after exposure to oxidative stress or heat shock [7577], one possible explanation is that snoRNAs could be leaving the nucleolus to regulate ESRE genes by methylating mRNAs.

Although this idea is intriguing, it appears to be mathematically implausible as a broad explanation for the mechanism of box C/D regulation of ESRE gene expression. Only approximately 50 box C/D snoRNAs are predicted in the genome of C. elegans. In contrast, the ESRE nucleotide motif is present in the promoter region of ~8% of all predicted genes (or about 1500 genes total) [22]. This numerical discrepancy makes it rather unlikely that a single snoRNA is responsible for the regulation of all ESRE genes, unless the snoRNA were to recognize the ESRE consensus sequence. Sequence comparisons suggest that none of the snoRNAs predicted in the C. elegans genome are obvious candidates for recognizing the ESRE motif. In all cases we are aware of, the hybridization sequence for snoRNAs is located between the C and D boxes, and no C. elegans box C/D snoRNA matches the ESRE consensus site.

An alternative hypothesis is that stress signals change snoRNP expression or targeting, changing rRNA modification patterns since most known box C/D snoRNP targets are in rRNA. Recent observations have shown that some of these sites are not saturated under normal growth conditions and that the degree to which some sites are modified has been linked with cellular stress [78]. This has led to the intriguing suggestion that different populations of ribosomes, perhaps with specific functions, may exist within cells. If this were the case, it would be reasonable to expect that one sub-population has specialized for stress-response genes, allowing rapid and dynamic switching of the translational profile of the cell to support survival. Indeed, a previous report has showed that ribosome methylation can regulate translation [79]. This is functionally analogous to the well-known integrated stress response, where phosphorylation of eIF-2α substantially reduces cap-dependent mRNA translation in favor of translation from structured mRNA elements called internal ribosomal entry sites, or IRESes [16]. snoRNA-mediated changes to the ribosome could similarly facilitate specialized translation of structured mRNAs.

If this were the case, one expected outcome would be increased ESRE gene expression during stress. But while we do see increased expression of ESRE genes during stress, this is at least partially due to transcriptional changes that we have measured using qRT-PCR; in contrast, we have not seen evidence of translational differences. Additionally, ESRE genes are not known to be activated by translational inhibitors like P. aeruginosa exotoxin A or hygromycin [1]. Targeting the 48S pre-initiation complex here (Fig 5A) also did not activate ESRE gene regulation. We also saw no changes in ESRE gene expression when components of the box H/ACA snoRNP complex were disrupted. rRNA modification by these ribonucleoprotein complexes is also important and would also be expected to affect transcription if this were a mechanism of ESRE gene regulation. Finally, stress-responsive ribosomal modifications wouldn’t explain the association of the box C/D snoRNP complexes with the ESRE motif. Ultimately, the data do not currently support this model.

Importantly, we found that immune effectors, such as irg-1 (S6A Fig and [42]) and irg-5 (Fig 6), were upregulated by the absence of box C/D snoRNPs. This is consistent with many reports that disruption of core cellular processes activates innate immune pathways [1,9,33]. In this case, the loss of box C/D snoRNPs activated irg-1 via translation suppression [42] and irg-5 through an unknown mechanism that may be related to mitochondrial dysfunction. Consistent with this, we saw increased host survival after box C/D snoRNP knockdown in a pathogenesis assay that depends on intestinal colonization. In contrast, the loss of the box C/D snoRNPs impaired worm survival in a pathogenesis setting where mitochondria are severely compromised (the Liquid Killing assay [58]), which may result from the combined mitochondrial disruption of box C/D loss and pathogen damage.

Interestingly, although the loss of ATF-7/ATF7 or PMK-1/p38 MAPK was able to completely abolish induction of irg-5 and several other immune genes after RNAi-mediated upregulation, the loss of box C/D snoRNPs still increased survival in atf-7(gk715) and pmk-1(km25) mutants. This suggests a different biological significance of the box C/D snoRNPs in modulating innate immunity and mitochondrial surveillance.

These data lead to a model where the box C/D snoRNPs act as a molecular switch that activates quality control pathways while inhibiting immune responses (Fig 10). Our data showed that box C/D snoRNPs are necessary for normal function of ESRE and UPRmt (and ATFS-1) and their disruption leads to increased basal Ptbb-6::GFP expression, consistent with previous findings where we and others [18,21] have showed that ATFS-1 may act to limit MAPKmt expression under normal conditions but works in concert to help restore cellular health under stress. The purpose of this novel mechanism may be to allow mitochondria an opportunity to repair before cellular defenses (which require larger energy expenditure) are activated. Future work will focus on understanding the relationships between these systems.

Fig 10. Proposed model of box C/D snoRNP roles in cellular pathways regulation.

Fig 10

Box C/D snoRNPs act as a molecular switch that suppresses innate immunity and activates mitochondrial pathways upon stress.

Materials and methods

C. elegans strains

All C. elegans strains were maintained on standard nematode growth medium (NGM) [80] seeded with Escherichia coli strain OP50 as a food source and were maintained at 20°C [80], unless otherwise noted. C. elegans strains used in this study included N2 Bristol (wild-type), SS104 [glp-4(bn2)], COP262 |knuSi221 [Pfib-1::FIB-1(genomic)::eGFP::fib-1 3’ UTR + unc-119(+)]| [81], WY703 |fdIs2 [3XESRE::GFP]; pFF4[rol-6(su1006)]| [27], SJ4100 |zcIs13 [Phsp-6::GFP]|,|atfs-1(et15); zcIs9 [Phsp-60::GFP]| [82], NVK235 (zcIs13; Patfs-1ΔESRE::ATFS-1WT) [21], SLR115 |dvIs67 [Ptbb-6::GFP + Pmyo-3::dsRed]| [18], AY101 |acIs101 [pDB09.1(Pirg-5::GFP); pRF4[rol-6(su1006)]]| [54], AU133 |agIs17[Pmyo-2::mCherry + Pirg-1::GFP]| [2], AU078 [PT24B8.5::GFP::unc-54 3’ UTR], VC1518 [atf-7(gk715)], and KU25 [pmk-1(km25)]. Worms were synchronized by hypochlorite isolation of eggs from gravid adults, followed by hatching of eggs in S Basal. 6,000 synchronized L1 larvae were transferred onto 10 cm NGM plates seeded with OP50. After transfer, worms were grown at 20°C for 46 hours prior to experiments, or for three days for production of the next cycle of eggs. Young adult hermaphrodites were used for all assays.

Bacterial strains

RNAi experiments in this study were done using RNAi-competent E. coli HT115 obtained from the Ahringer or Vidal RNAi libraries [83,84]. Luciferase (L4440::Luc) RNAi-expressing E. coli was obtained from the Antebi Lab [85]. All RNAi plasmids were sequence-verified prior to use. P. aeruginosa strain PA14 was used for all infectious assays [86].

RNA interference protocol

RNAi-expressing E. coli were cultured and seeded onto NGM plates supplemented with 25 μg/mL carbenicillin and 1 mM IPTG. When double RNAi was performed, bacterial cultures were mixed in a 1:1 ratio. For RNAi experiments starting at L1, 2,000 synchronized L1 larvae were transferred onto 6 cm RNAi plates and grown at 20°C for 46 hours prior to imaging or exposure to chemical compounds or pathogens. For RNAi experiment starting at L3, 2,500 synchronized L1 larvae were transferred onto 6 cm regular NGM plates seeded with OP50 and grown at 20°C for 22 hours until reaching the L3 stage. Worms were then washed off plates, rinsed three times, and transferred onto RNAi plates. Worms were grown at 20°C for 24 hours on RNAi plates prior to use for experiments.

Biochemical assays

Synchronized young adult worms were exposed to 1 mM 1,1-phenanthroline for 20 hours, 50 μM rotenone for 14 hours, or DMSO (solvent control). After exposure, worms were collected in 15 mL conical tubes and washed three times to remove residual compounds, and snap frozen in liquid nitrogen. Frozen worm pellets were homogenized using a Dounce homogenizer with the appropriate volume of Cytoplasmic Extraction Reagent I (NE-PER Nuclear and Cytoplasmic Extraction Reagents, Thermo Scientific). Cytoplasmic and nuclear protein extraction was then performed according to the manufacturer’s protocol. Extracts were immediately used for electrophoretic mobility shift assay (EMSA) and oligo pulldown, otherwise were stored at 4°C (maximum for a week).

EMSA was performed by incubating worms’ nuclear-enriched extract for 20 minutes at room temperature with biotinylated oligos (4XESRE or mutated 4XESRE) (ordered from IDT) as bait in Binding Buffer (50 ng/μL poly (dI•dC), 5% glycerol, 0.1% NP-40, 2.5 mM MgCl2, 1 mM EDTA, and 20 fmol biotinylated oligos). Binding reactions were then loaded for on a polyacrylamide gel and run until the dye front had migrated ¾ down the length of the gel. Material was then transferred to a nylon membrane for 30 minutes at 380 mA. DNA on the membrane was then crosslinked at 120 mJ/cm2 using ultraviolet light. Biotin-labeled DNA was then detected using the LightShift Chemiluminescent EMSA Kit (Thermo Scientific) and exposed to X-ray film.

Oligo pulldown was performed according to the manual for DynaBeads M-280 Streptavidin (Invitrogen). In short, magnetic beads were first washed with Binding and Washing buffer (BW 2X) (10 mM Tris-HCl pH 7.5, 1 mM EDTA, and 2 M NaCl). Beads were then coupled with the biotinylated-4XESRE oligos bait for 15 minutes (with BW 1X). Coated beads were resuspended in PBS buffer (0.1 M phosphate, 0.15 M NaCl) pH 7.4 and then incubated with worm nuclear extract for 2 hours at room temperature, washed, and eluted. Elution samples were sent for tandem MS/MS.

C. elegans size measurement

Synchronized young adult glp-4(bn2) worms were washed from NGM plates seeded with RNAi-expressing E. coli HT115 into a 15 mL conical tube and rinsed three times. Worm size was determined via flow vermimetry by using COPAS Biosort machine (Union Biometrica).

C. elegans lifespan assay

50 young adult glp-4(bn2) worms were transferred onto NGM plates seeded with E. coli OP50 and incubated at 25°C. Worms were scored daily to obtain survival curves; dead worms were removed from assay plates. Three technical replicates (total: 150 worms per condition) in each of the three biological replicates were performed. Worms that left the surface of the plates were censored from analysis.

C. elegans chemical exposure assays

Synchronized young adult worms were washed from NGM plates seeded with E. coli OP50 or with RNAi-expressing E. coli HT115 into 15 mL conical tubes and rinsed three times. Worms were then sorted into a 96-well plate (~100 worms/well). S Basal supplemented with 50 μM rotenone (Sigma), 2 mg/mL cycloheximide (Sigma), or DMSO (solvent control) was then added into the wells of the 96-well plate to a final volume of 100 μL. Worms were imaged with Cytation5 automated microscope every two hours for 20 hours at room temperature [87]. At least three biological replicates were performed for each experiment.

Quantitative reverse transcriptase PCR (qRT-PCR)

8,000 young adult worms were used for RNA extraction, and subsequent qRT-PCR was performed as previously described [58]. Prior to RNA extraction, worms were reared on RNAi plates starting at the L1 or L3 stage, as described above. For treatment with rotenone, young adult worms were washed off plates, rinsed three times, and were incubated for 8 hours in S Basal supplemented with 25 μM rotenone or a corresponding volume of DMSO control. For each experiment, at least three biological replicates were performed. Primer sequences are listed on S5 Table.

C. elegans pathogenesis assays

P. aeruginosa liquid pathogenesis model (Liquid Killing or LK) was performed essentially as described [58,88]. 25 synchronized young adult worms were sorted into each well of a 384-well plate. Liquid Killing medium was mixed with P. aeruginosa PA14 (final OD600: 0.03) and then added into each well. Plates were incubated at 25°C. At varying time points, plates were washed three times and worms were stained with SYTOX Orange nucleic acid stain (Invitrogen) for 12 hours to identify dead worms. Plates were then washed and imaged with a Cytation5 automated microscope and the fraction of dead worms was autonomously quantified with CellProfiler.

P. aeruginosa agar pathogenesis model (Slow Killing or SK) was performed as previously described [89]. 50 young adult worms were transferred onto PA14-SK plates and incubated at 25°C. Worms were scored daily to obtain survival curves; dead worms were removed from assay plates and worms that left the surface of the plate were censored from data analysis.

P. aeruginosa exposure to worms carrying Pirg-5::GFP (AY101) was performed similarly as SK assay. 500 worms were transferred onto PA14-SK plates. After 8 hours, worms were washed off plates and transferred into a 96-well plate and washed five times to remove bacteria. Imaging and GFP quantification were performed with Cytation5 automated microscope and Gen5 3.0 software.

Colony forming unit (CFU) assay

18 worms were collected from a Slow Killing agar plate after 48 hours of exposure. Worms were washed three times to remove residual bacteria and the volume was aspirated to 100 μL. 100 μL of carbide beads were added, and tubes were vortexed vigorously to break open the worms. Supernatant was serially diluted and plated on LB plates, incubated overnight, and colonies were counted the next day. Assays were performed in triplicate.

Microscopy

For visualization of the worm reporter strain COP262 (Pfib-1::FIB-1::eGFP), worms were immobilized using 1 mM levamisole and then transferred onto a 3% noble agar pad. Three biological replicates with at least 20 worms per replicate were imaged using fluorescence microscope (Zeiss ApoTome.2 Imager.M2, Carl Zeiss, Germany) with 63x magnification. Pfib-1::FIB-1::eGFP fluorescence in the intestine of each animal was imaged and quantified.

Fluorescence quantification

For visualization of the worm reporter strains AU078, AU133, AY101, NVK235, SJ4100, SLR115, and WY703 in 96-well plates, Cytation5 Cell Imaging Multi-Mode Reader (BioTek Instruments) was used. All imaging experiments were performed with identical settings between replicates of each assay. Imaging settings were optimized depending on the strength of the reporter’s signal. GFP quantification was performed by using Gen5 3.0 software and/or via flow vermimetry (COPAS Biosort machine from Union Biometrica) [87].

For fluorescence quantification of the worm reporter strain COP262, flow vermimetry (COPAS Biosort machine, Union Biometrica) was used. For quantification of the area of FIB-1::eGFP fluorescence, ImageJ [90] was used. In short, images were converted to 16-bit and threshold was adjusted to identify fluorescent regions. Particles with the minimum size of 700 pixels2 were then selected throughout the image and the area was calculated by the software.

Mitochondrial membrane potential and mitochondrial mass quantification

Approximately 400 N2 worms were washed off RNAi plates and transferred to 4 wells of a 96-well plate (~100 worms per well). Fluorescent dye (4.375 μM of MitoTracker Red or 4.375 μM of MitoTracker Green) or an appropriate volume of DMSO control was then added into each well. After 1 hour of incubation, worms were washed three times to remove any remaining dye. Fluorescence measurements were taken via flow vermimetry (COPAS Biosort, Union Biometrica). At least three biological replicates were performed.

Oxygen consumption rate measurement

6,000 N2 worms per condition (reared on E. coli expressing empty vector or targeting box C/D snoRNPs RNAi; untreated or treated with DMSO or 25 μM rotenone for 8 hours) were pipetted into the biological oxygen monitor instrument (YSI 5300). Oxygen consumption was measured for ten minutes by using the monitor with a Clark-type oxygen electrode (YSI 5301, Yellow Springs Instrument) at 20°C as previously described [91]. At least three biological replicates were performed.

Statistical analysis

All numerical data underlying all graphs can be found in S1 Data. RStudio (version 3.6.3) was used to perform statistical analysis. One-way or two-way analysis of variance (ANOVA) were performed to calculate the significance of a condition or treatment when there were three or more groups in the experimental setting. The statistically significant experimental results as determined via ANOVA were then followed by Dunnett’s test (R package DescTools, version 0.99.34) to calculate statistical significance or p values between each group compared to the control group. Student’s t-test analyses were performed to calculate the p values when comparing two groups in an experimental setting. A Log-rank test (http://bioinf.wehi.edu.au/software/russell/logrank/) was performed to calculate the p values in the lifespan and Slow Killing assays. Dunnett’s test, Student’s t-test, and log-rank test results were indicated in graphs as follows: NS not significant, *p < 0.05, **p < 0.01, and ***p < 0.001.

Supporting information

S1 Fig. Proteomic assays revealed the presence of ESRE-binding factor(s).

Electrophoretic mobility shift assay (EMSA) showed the presence of the ESRE-binding motif through the identified ‘Shift’. Worms were treated with DMSO or 50 μM rotenone for 14 hours. D: DMSO-treated, R: rotenone-treated, 4xESRE: oligo bait, and 4xESRE(M): oligo bait with mutations.

(TIFF)

S2 Fig. The use of RNAi targeting luciferase yielded in similar results of multiple reporters’ expressions as compared to empty vector control in both single and double RNAi settings.

(A) Quantification of GFP fluorescence of C. elegans carrying 3XESRE::GFP that were reared on E. coli expressing RNAi targeting empty vector (EV) or luciferase. Worms were treated for 8 hours with vehicle (DMSO) or 25 μM rotenone. RNAi was started at L1 (left) or L3 stage (right). (B) Quantification of GFP fluorescence of C. elegans carrying Phsp-6::GFP (top) and Ptbb-6::GFP (bottom) reporters that were reared on E. coli expressing RNAi targeting empty vector (EV) or luciferase. Double RNAi was performed with empty vector (EV) or luciferase, or spg-7(RNAi). Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from Student’s t-test. GFP values were normalized to EV-DMSO or EV. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In (A), purple significance marks indicate comparison of luciferase(RNAi) to EV(RNAi) in DMSO, red marks indicate comparison of luciferase(RNAi) to EV(RNAi) in rotenone, and black marks indicate comparison between expressions in rotenone and DMSO. In (B), red significance marks indicate comparison between luciferase(RNAi) to the corresponding condition but with EV(RNAi), e.g., fib-1;luciferase(RNAi) vs. fib-1;EV(RNAi) and spg-7;luciferase(RNAi) vs spg-7;EV(RNAi).

(TIF)

S3 Fig. Knockdown of box C/D snoRNP assembly factor RUVB-1 slightly affected mitochondrial surveillance pathways.

Quantification of GFP fluorescence of C. elegans carrying (A) 3XESRE::GFP, (B) Phsp-6::GFP, and (C) Ptbb-6::GFP reporters that were reared on E. coli expressing RNAi targeting empty vector (EV) or ruvb-1/RUVB. In (A), worms were treated for 8 hours with vehicle (DMSO) or 50 μM rotenone. In (B, C), double RNAi was performed with empty vector (EV) or spg-7(RNAi). (D) Images and fluorescence intensity quantification of C. elegans carrying Pfib-1::FIB-1::eGFP reporter that were reared on E. coli expressing RNAi targeting empty vector (EV), fib-1/FBL, or ruvb-1/RUVB. RNAi was started at L1 or L3 stage as indicated in the figure. Three biological replicates with (A-C) ~400 worms/replicate or (D) ~25 worms/replicate were analyzed. p-values were determined from Student’s t-test. GFP values were normalized to EV-DMSO or EV. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In (A-C), purple significance marks indicate comparison of ruvb-1(RNAi) to EV(RNAi) in unstressed condition (DMSO or EV(RNAi)), red marks indicate comparison of ruvb-1(RNAi) to EV(RNAi) in stressed condition (rotenone or spg-7(RNAi)), and black marks indicate comparison between stressed and unstressed conditions.

(TIFF)

S4 Fig. RNAi targeting core members of box H/ACA snoRNPs did not affect mitochondrial surveillance pathways.

Quantification of GFP fluorescence of C. elegans carrying (A) 3XESRE::GFP, (B) Phsp-6::GFP, or (C) Ptbb-6::GFP reporters that were reared on E. coli expressing empty vector (EV) or RNAi targeting box H/ACA snoRNP members: nola-3/Nop10, Y48A6B.3/Nhp2, or Y66H1A.4/Gar1. In (A), worms were treated for 8 hours with vehicle (DMSO) or 50 μM rotenone. In (B, C), double RNAi was performed with empty vector (EV) or spg-7(RNAi). Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from two-way ANOVA, followed by Dunnett’s test, and Student’s t-test. All fold changes were normalized to DMSO-EV or EV control. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In all panels, purple significance marks indicate comparison of H/ACA genes(RNAi) to EV(RNAi) in unstressed condition (DMSO or EV(RNAi)), red marks indicate comparison of H/ACA genes(RNAi) to EV(RNAi) in stressed condition (rotenone or spg-7(RNAi)), and black marks indicate comparison between stressed and unstressed conditions.

(TIF)

S5 Fig. Quantitative RT-PCR verified reduction of transcripts in RNAi targeting members of box H/ACA and eukaryotic 48S transcription initiation complex.

mRNA levels of target genes in N2 worms reared on E. coli expressing RNAi targeting Y48A6B.3, clu-1/eIF3A, ife-2/ eIF4E, or inf-1/eIF4A. Three biological replicates with ~8,000 worms/replicate were analyzed. All fold changes were normalized to expression of target genes in worms reared on EV(RNAi)-expressing E. coli.

(TIF)

S6 Fig. Knockdown of box C/D snoRNPs induced immune response gene irg-1.

(A, B) Quantification of GFP fluorescence of C. elegans carrying Pirg-1::GFP reporter that (A) were reared on E. coli expressing empty vector (EV), fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi) or (B) exposed to 2 mg/mL cycloheximide or DMSO control for 8 hours. Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from (A) one-way ANOVA, followed by Dunnett’s test or (B) Student’s t-test. All fold changes were normalized to EV or DMSO control. *p < 0.05, ** p < 0.01.

(TIF)

S7 Fig. Cycloheximide treatment did not affect mitochondrial surveillance pathways.

Quantification of GFP fluorescence of C. elegans carrying (A) 3XESRE::GFP or (B) Ptbb-6::GFP reporters that were treated for 8 hours with vehicle (DMSO) or 2 mg/mL of translation elongation inhibitor cycloheximide. Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from Student’s t-test. NS not significant.

(TIF)

S8 Fig. RNAi targeting core members of box H/ACA snoRNPs did not affect innate immune pathways.

Quantification of GFP fluorescence of C. elegans carrying (A) Pirg-1::GFP or (B) Pirg-5::GFP reporters that were reared on E. coli expressing empty vector (EV) or RNAi targeting box H/ACA snoRNP members: nola-3/Nop10, Y48A6B.3/Nhp2, or Y66H1A.4/Gar1. Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from one-way ANOVA, followed by Dunnett’s test. All fold changes were normalized to EV control. NS not significant.

(TIF)

S9 Fig. RNAi targeting box C/D snoRNPs provides protection in atf-7(gk715) and pmk-1(km25) mutants in agar pathogenesis model.

(A, B) Survival of N2 wild-type, atf-7(gk715), or pmk-1(km25) mutants reared on RNAi strains targeting empty vector (EV) and (A) nol-56 or (B) nol-58. Three biological replicates with ~150 worms/replicate were analyzed. Representative replicates are shown. p-values were determined from log-rank test. *** p < 0.001. Purple significance marks indicate comparison of atf-7(gk715) or pmk-1(km25) mutants to N2 wild-type (reared on EV(RNAi)), red marks indicate comparison of atf-7(gk715) or pmk-1(km25) mutants to N2 wild-type (reared on nol-56(RNAi) or nol-58(RNAi)), and black marks indicate comparison between nol-56(RNAi) or nol-58(RNAi) vs. EV(RNAi) for each worm strain.

(TIF)

S1 Table. List of 75 protein candidates obtained from mass spectrometry.

(XLSX)

S2 Table. Raw data of lifespan measurement of glp-4(bn2) worms.

Animals were reared on RNAi targeting box C/D snoRNPs or empty vector control. Raw data of 3 replicates were shown.

(XLSX)

S3 Table. Raw data of survival of glp-4(bn2) worms under Slow Killing assay.

Animals were reared on RNAi targeting box C/D snoRNPs or empty vector control. Raw data of 3 replicates were shown.

(XLSX)

S4 Table. Raw data of survival of N2 wild-type and atf-7(gk715) and pmk-1(km25) mutants under Slow Killing assay.

Worms were reared on RNAi targeting box C/D snoRNPs or empty vector control. Raw data of 3 replicates were shown.

(XLSX)

S5 Table. Sequences of forward and reverse primers for quantitative RT-PCR experiments used in this study.

(XLSX)

S1 Data. Numerical data underlying all graphs.

(XLSX)

Acknowledgments

C. elegans strains used were provided by David Fay, Cole Haynes, or obtained from the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). E. coli expressing luciferase(RNAi) was provided by the laboratory of Adam Antebi.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

NVK, a CPRIT scholar in Cancer Research, thanks the Cancer Prevention and Research Institute of Texas (CPRIT, https://www.cprit.state.tx.us/) for their generous support, CPRIT grant RR150044. This work was also supported by the National Institutes of Health (NIGMS R35GM129294, https://www.nigms.nih.gov/) to NVK. Funders play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.McEwan Deborah L, Kirienko Natalia V, Ausubel Frederick M. Host Translational Inhibition by Pseudomonas aeruginosa Exotoxin A Triggers an Immune Response in Caenorhabditis elegans. Cell Host & Microbe. 2012;11(4):364–74. doi: 10.1016/j.chom.2012.02.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dunbar Tiffany L, Yan Z, Balla Keir M, Smelkinson Margery G, Troemel Emily R. C. elegans Detects Pathogen-Induced Translational Inhibition to Activate Immune Signaling. Cell Host & Microbe. 2012;11(4):375–86. doi: 10.1016/j.chom.2012.02.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Doye A, Mettouchi A, Bossis G, Clément R, Buisson-Touati C, Flatau G, et al. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell. 2002;111(4). doi: 10.1016/s0092-8674(02)01132-7 . [DOI] [PubMed] [Google Scholar]
  • 4.Garcia-Sanchez JA, Ewbank JJ, Visvikis O. Ubiquitin-related processes and innate immunity in C. elegans. Cell Mol Life Sci. 2021. Epub 2021/02/26. doi: 10.1007/s00018-021-03787-w . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jones LM, Chen Y, van Oosten-Hawle P. Redefining proteostasis transcription factors in organismal stress responses, development, metabolism, and health. Biol Chem. 2020;401(9):1005–18. Epub 2020/03/07. doi: 10.1515/hsz-2019-0385 . [DOI] [PubMed] [Google Scholar]
  • 6.Stradal TEB, Schelhaas M. Actin dynamics in host-pathogen interaction. FEBS Lett. 2018;592(22):3658–69. Epub 2018/06/24. doi: 10.1002/1873-3468.13173 ; PubMed Central PMCID: PMC6282728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Alshareef MH, Hartland EL, McCaffrey K. Effectors Targeting the Unfolded Protein Response during Intracellular Bacterial Infection. Microorganisms. 2021;9(4). Epub 2021/04/04. doi: 10.3390/microorganisms9040705 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Choi JA, Song CH. Insights Into the Role of Endoplasmic Reticulum Stress in Infectious Diseases. Front Immunol. 2019;10:3147. Epub 2020/02/23. doi: 10.3389/fimmu.2019.03147 ; PubMed Central PMCID: PMC7005066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Melo Justine A, Ruvkun G. Inactivation of Conserved C. elegans Genes Engages Pathogen- and Xenobiotic-Associated Defenses. Cell. 2012;149(2):452–66. doi: 10.1016/j.cell.2012.02.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lemichez E, Barbieri J. General aspects and recent advances on bacterial protein toxins. Cold Spring Harbor perspectives in medicine. 2013;3(2). doi: 10.1101/cshperspect.a013573 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Khan S, Raj D, Jaiswal K, Lahiri A. Modulation of host mitochondrial dynamics during bacterial infection. Mitochondrion. 2020;53:140–9. Epub 2020/05/30. doi: 10.1016/j.mito.2020.05.005 . [DOI] [PubMed] [Google Scholar]
  • 12.Tiku V, Tan MW, Dikic I. Mitochondrial Functions in Infection and Immunity. Trends Cell Biol. 2020;30(4):263–75. Epub 2020/03/24. doi: 10.1016/j.tcb.2020.01.006 ; PubMed Central PMCID: PMC7126537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cho DH, Kim JK, Jo EK. Mitophagy and Innate Immunity in Infection. Mol Cells. 2020;43(1):10–22. Epub 2020/01/31. doi: 10.14348/molcells.2020.2329 ; PubMed Central PMCID: PMC6999710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bader V, Winklhofer KF. PINK1 and Parkin: team players in stress-induced mitophagy. Biol Chem. 2020;401(6–7):891–9. Epub 2020/04/17. doi: 10.1515/hsz-2020-0135 . [DOI] [PubMed] [Google Scholar]
  • 15.Youle RJ, Narendra DP. Mechanisms of mitophagy. Nature reviews Molecular cell biology. 2011;12(1):9–14. Epub 2010/12/24. doi: 10.1038/nrm3028 ; PubMed Central PMCID: PMC4780047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Anderson NS, Haynes CM. Folding the Mitochondrial UPR into the Integrated Stress Response. Trends Cell Biol. 2020;30(6):428–39. Epub 2020/05/16. doi: 10.1016/j.tcb.2020.03.001 ; PubMed Central PMCID: PMC7230072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fiorese CJ, Haynes CM. Integrating the UPR(mt) into the mitochondrial maintenance network. Crit Rev Biochem Mol Biol. 2017;52(3):304–13. Epub 2017/03/10. doi: 10.1080/10409238.2017.1291577 ; PubMed Central PMCID: PMC5571472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Munkácsy E, Khan MH, Lane RK, Borror MB, Park JH, Bokov AF, et al. DLK-1, SEK-3 and PMK-3 Are Required for the Life Extension Induced by Mitochondrial Bioenergetic Disruption in C. elegans. PLOS Genetics. 2016;12(7):e1006133. doi: 10.1371/journal.pgen.1006133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Oks O, Lewin S, Goncalves IL, Sapir A. The UPR(mt) Protects Caenorhabditis elegans from Mitochondrial Dysfunction by Upregulating Specific Enzymes of the Mevalonate Pathway. Genetics. 2018;209(2):457–73. Epub 2018/03/31. doi: 10.1534/genetics.118.300863 ; PubMed Central PMCID: PMC5972420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Tjahjono E, Kirienko NV. A conserved mitochondrial surveillance pathway is required for defense against Pseudomonas aeruginosa. PLoS Genet. 2017;13(6):e1006876. Epub 2017/07/01. doi: 10.1371/journal.pgen.1006876 ; PubMed Central PMCID: PMC5510899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tjahjono E, McAnena AP, Kirienko NV. The evolutionarily conserved ESRE stress response network is activated by ROS and mitochondrial damage. BMC Biology. 2020;18(1):74. doi: 10.1186/s12915-020-00812-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kirienko NV, Fay DS. SLR-2 and JMJC-1 regulate an evolutionarily conserved stress-response network. EMBO J. 2010;29(4):727–39. Epub 2010/01/09. doi: 10.1038/emboj.2009.387 ; PubMed Central PMCID: PMC2829162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kwon JY, Hong M, Choi MS, Kang S, Duke K, Kim S, et al. Ethanol-response genes and their regulation analyzed by a microarray and comparative genomic approach in the nematode Caenorhabditis elegans. Genomics. 2004;83(4):600–14. doi: 10.1016/j.ygeno.2003.10.008 [DOI] [PubMed] [Google Scholar]
  • 24.Pignataro L, Varodayan FP, Tannenholz LE, Protiva P, Harrison NL. Brief alcohol exposure alters transcription in astrocytes via the heat shock pathway. Brain Behav. 2013;3(2):114–33. Epub 2013/03/28. doi: 10.1002/brb3.125 ; PubMed Central PMCID: PMC3607153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kirienko NV, Ausubel FM, Ruvkun G. Mitophagy confers resistance to siderophore-mediated killing by Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences. 2015;112(6):1821–6. doi: 10.1073/pnas.1424954112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kang D, Kirienko DR, Webster P, Fisher AL, Kirienko NV. Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response. Virulence. 2018;9(1):804–17. doi: 10.1080/21505594.2018.1449508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kuzmanov A, Karina EI, Kirienko NV, Fay DS. The Conserved PBAF Nucleosome-Remodeling Complex Mediates the Response to Stress in Caenorhabditis elegans. Molecular and Cellular Biology. 2014;34(6):1121–35. doi: 10.1128/MCB.01502-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kirienko NV, McEnerney JD, Fay DS. Coordinated regulation of intestinal functions in C. elegans by LIN-35/Rb and SLR-2. PLoS Genet. 2008;4(4):e1000059. Epub 2008/04/26. doi: 10.1371/journal.pgen.1000059 ; PubMed Central PMCID: PMC2312330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pellegrino MW, Nargund AM, Kirienko NV, Gillis R, Fiorese CJ, Haynes CM. Mitochondrial UPR-regulated innate immunity provides resistance to pathogen infection. Nature. 2014;516(7531):414–7. doi: 10.1038/nature13818 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jeong D, Lee D, Hwang S, Lee Y, Lee J, Seo M, et al. Mitochondrial chaperone HSP-60 regulates anti-bacterial immunity via p38 MAP kinase signaling. The EMBO journal. 2017;36(8):1046–65. doi: 10.15252/embj.201694781 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Deng P, Uma Naresh N, Du Y, Lamech LT, Yu J, Zhu LJ, et al. Mitochondrial UPR repression during Pseudomonas aeruginosa infection requires the bZIP protein ZIP-3. Proceedings of the National Academy of Sciences. 2019;116(13):6146–51. doi: 10.1073/pnas.1817259116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Campos J, Wu Z, Rudich P, Soo S, Mistry M, Ferreira J, et al. Mild mitochondrial impairment enhances innate immunity and longevity through ATFS-1 and p38 signaling. EMBO reports. 2021;22(12):e52964. doi: 10.15252/embr.202152964 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Pukkila-Worley R. Surveillance Immunity: An Emerging Paradigm of Innate Defense Activation in Caenorhabditis elegans. PLoS Pathog. 2016;12(9):e1005795. Epub 2016/09/16. doi: 10.1371/journal.ppat.1005795 ; PubMed Central PMCID: PMC5025020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Anderson S, Cheesman H, Peterson N, Salisbury J, Soukas A, Pukkila-Worley R. The fatty acid oleate is required for innate immune activation and pathogen defense in Caenorhabditis elegans. PLoS pathogens. 2019;15(6). doi: 10.1371/journal.ppat.1007893 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Dasgupta M, Shashikanth M, Gupta A, Sandhu A, De A, Javed S, et al. NHR-49 Transcription Factor Regulates Immunometabolic Response and Survival of Caenorhabditis elegans during Enterococcus faecalis Infection. Infection and immunity. 2020;88(8). doi: 10.1128/IAI.00130-20 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ellis J, Brown D, Brown J. The small nucleolar ribonucleoprotein (snoRNP) database. RNA (New York, NY). 2010;16(4). doi: 10.1261/rna.1871310 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ojha S, Malla S, Lyons SM. snoRNPs: Functions in Ribosome Biogenesis. Biomolecules. 2020;10(5):783. doi: 10.3390/biom10050783 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Massenet S, Bertrand E, Verheggen C. Assembly and trafficking of box C/D and H/ACA snoRNPs. RNA Biol. 2017;14(6):680–92. Epub 2016/10/08. doi: 10.1080/15476286.2016.1243646 ; PubMed Central PMCID: PMC5519232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Lee J, Harris AN, Holley CL, Mahadevan J, Pyles KD, Lavagnino Z, et al. Rpl13a small nucleolar RNAs regulate systemic glucose metabolism. Journal of Clinical Investigation. 2016;126(12):4616–25. doi: 10.1172/JCI88069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Elliott B, Ho H, Ranganathan S, Vangaveti S, Ilkayeva O, Abou A. H, et al. Modification of messenger RNA by 2’-O-methylation regulates gene expression in vivo. Nature communications. 2019;10(1). doi: 10.1038/s41467-019-11375-7 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Tiku V, Jain C, Raz Y, Nakamura S, Heestand B, Liu W, et al. Small nucleoli are a cellular hallmark of longevity. Nature communications. 2017;8. doi: 10.1038/ncomms16083 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Tiku V, Kew C, Mehrotra P, Ganesan R, Robinson N, Antebi A. Nucleolar fibrillarin is an evolutionarily conserved regulator of bacterial pathogen resistance. Nature Communications. 2018;9(1):3607. doi: 10.1038/s41467-018-06051-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Liang J, Wen J, Huang Z, Chen X, Zhang B, Chu L. Small Nucleolar RNAs: Insight Into Their Function in Cancer. Frontiers in oncology. 2019;9. doi: 10.3389/fonc.2019.00587 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Mosser D, Kotzbauer P, Sarge K, Morimoto R. In vitro activation of heat shock transcription factor DNA-binding by calcium and biochemical conditions that affect protein conformation. Proceedings of the National Academy of Sciences of the United States of America. 1990;87(10). doi: 10.1073/pnas.87.10.3748 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Saltzman A, Leng M, Bhatt B, Singh P, Chan D, Dobrolecki L, et al. gpGrouper: A Peptide Grouping Algorithm for Gene-Centric Inference and Quantitation of Bottom-Up Proteomics Data. Molecular & cellular proteomics: MCP. 2018;17(11). doi: 10.1074/mcp.TIR118.000850 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Lafontaine DL, Tollervey D. Synthesis and assembly of the box C+D small nucleolar RNPs. Mol Cell Biol. 2000;20(8):2650–9. Epub 2000/03/25. doi: 10.1128/MCB.20.8.2650-2659.2000 ; PubMed Central PMCID: PMC85480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sheaffer KL, Updike DL, Mango SE. The Target of Rapamycin Pathway Antagonizes pha-4/FoxA to Control Development and Aging. Current Biology. 2008;18(18):1355–64. doi: 10.1016/j.cub.2008.07.097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ahringer J. Reverse Genetics. WormBook. 2006. doi: 10.1895/wormbook.1.79.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM. Mitochondrial Import Efficiency of ATFS-1 Regulates Mitochondrial UPR Activation. Science. 2012;337(6094):587–90. doi: 10.1126/science.1223560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Erales J, Marchand V, Panthu B, Gillot S, Belin S, Ghayad SE, et al. Evidence for rRNA 2′-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes. Proceedings of the National Academy of Sciences. 2017;114(49):12934–9. doi: 10.1073/pnas.1707674114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Penzo M, Montanaro L. Turning Uridines around: Role of rRNA Pseudouridylation in Ribosome Biogenesis and Ribosomal Function. Biomolecules. 2018;8(2). doi: 10.3390/biom8020038 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Kavčič B, Tkačik G, Bollenbach T. Mechanisms of drug interactions between translation-inhibiting antibiotics. Nature communications. 2020;11(1). doi: 10.1038/s41467-020-17734-z . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Rodnina M. The ribosome in action: Tuning of translational efficiency and protein folding. Protein science: a publication of the Protein Society. 2016;25(8). doi: 10.1002/pro.2950 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Bolz DD, Tenor JL, Aballay A. A Conserved PMK-1/p38 MAPK Is Required in Caenorhabditis elegans Tissue-specific Immune Response to Yersinia pestis Infection. Journal of Biological Chemistry. 2010;285(14):10832–40. doi: 10.1074/jbc.M109.091629 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Pukkila-Worley R, Feinbaum R, Kirienko NV, Larkins-Ford J, Conery AL, Ausubel FM. Stimulation of Host Immune Defenses by a Small Molecule Protects C. elegans from Bacterial Infection. PLoS Genetics. 2012;8(6):e1002733. doi: 10.1371/journal.pgen.1002733 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Shivers RP, Pagano DJ, Kooistra T, Richardson CE, Reddy KC, Whitney JK, et al. Phosphorylation of the Conserved Transcription Factor ATF-7 by PMK-1 p38 MAPK Regulates Innate Immunity in Caenorhabditis elegans. PLoS Genetics. 2010;6(4):e1000892. doi: 10.1371/journal.pgen.1000892 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Peterson N, Cheesman H, Liu P, Anderson S, Foster K, Chhaya R, et al. The nuclear hormone receptor NHR-86 controls anti-pathogen responses in C. elegans. PLoS genetics. 2019;15(1). doi: 10.1371/journal.pgen.1007935 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kirienko Natalia V, Kirienko Daniel R, Larkins-Ford J, Wählby C, Ruvkun G, Ausubel Frederick M. Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death. Cell Host & Microbe. 2013;13(4):406–16. doi: 10.1016/j.chom.2013.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kang D, Kirienko NV. An In Vitro Cell Culture Model for Pyoverdine-Mediated Virulence. Pathogens. 2020;10(1). Epub 2020/12/31. doi: 10.3390/pathogens10010009 ; PubMed Central PMCID: PMC7824568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Kang D, Revtovich AV, Chen Q, Shah KN, Cannon CL, Kirienko NV. Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients. Front Microbiol. 2019;10:2048. Epub 2019/09/26. doi: 10.3389/fmicb.2019.02048 ; PubMed Central PMCID: PMC6743535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Feinbaum RL, Urbach JM, Liberati NT, Djonovic S, Adonizio A, Carvunis AR, et al. Genome-wide identification of Pseudomonas aeruginosa virulence-related genes using a Caenorhabditis elegans infection model. PLoS Pathog. 2012;8(7):e1002813. Epub 2012/08/23. doi: 10.1371/journal.ppat.1002813 ; PubMed Central PMCID: PMC3406104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, Miyata S, et al. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol. 2006;7(10):R90. Epub 2006/10/14. doi: 10.1186/gb-2006-7-10-r90 ; PubMed Central PMCID: PMC1794565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, Inoue H, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science. 2002;297(5581):623–6. Epub 2002/07/27. doi: 10.1126/science.1073759 . [DOI] [PubMed] [Google Scholar]
  • 64.Kim DH, Liberati NT, Mizuno T, Inoue H, Hisamoto N, Matsumoto K, et al. Integration of Caenorhabditis elegans MAPK pathways mediating immunity and stress resistance by MEK-1 MAPK kinase and VHP-1 MAPK phosphatase. Proc Natl Acad Sci U S A. 2004;101(30):10990–4. Epub 2004/07/17. doi: 10.1073/pnas.0403546101 ; PubMed Central PMCID: PMC503731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2006;2(11):e183. Epub 2006/11/14. doi: 10.1371/journal.pgen.0020183 ; PubMed Central PMCID: PMC1635533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Hummell NA, Revtovich AV, Kirienko NV. Novel Immune Modulators Enhance Caenorhabditis elegans Resistance to Multiple Pathogens. mSphere. 2021;6(1). Epub 2021/01/08. doi: 10.1128/mSphere.00950-20 ; PubMed Central PMCID: PMC7845594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Estes KA, Dunbar TL, Powell JR, Ausubel FM, Troemel ER. bZIP transcription factor zip-2 mediates an early response to Pseudomonas aeruginosa infection in Caenorhabditis elegans. Proceedings of the National Academy of Sciences. 2010;107(5):2153–8. doi: 10.1073/pnas.0914643107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Martineau C, Kirienko N, Pujol N. Innate immunity in C. elegans. Current topics in developmental biology. 2021;144:309–51. doi: 10.1016/bs.ctdb.2020.12.007 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Min K, Lee J. RNA interference in C. elegans: History, application, and perspectives. Integrative Biosciences. 2007;11(2):99–104. doi: 10.1080/17386357.2007.9647321 [DOI] [Google Scholar]
  • 70.De-Souza E, Camara H, Salgueiro W, Moro R, Knittel T, Tonon G, et al. RNA interference may result in unexpected phenotypes in Caenorhabditis elegans. Nucleic acids research. 2019;47(8):3957–69. doi: 10.1093/nar/gkz154 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Vitali P, Basyuk E, Le Meur E, Bertrand E, Muscatelli F, Cavaille J, et al. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. J Cell Biol. 2005;169(5):745–53. Epub 2005/06/09. doi: 10.1083/jcb.200411129 ; PubMed Central PMCID: PMC2171610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Vitali P, Kiss T. Cooperative 2’-O-methylation of the wobble cytidine of human elongator tRNA(Met)(CAT) by a nucleolar and a Cajal body-specific box C/D RNP. Genes Dev. 2019;33(13–14):741–6. Epub 2019/06/07. doi: 10.1101/gad.326363.119 ; PubMed Central PMCID: PMC6601510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Aw JG, Shen Y, Wilm A, Sun M, Lim XN, Boon KL, et al. In Vivo Mapping of Eukaryotic RNA Interactomes Reveals Principles of Higher-Order Organization and Regulation. Mol Cell. 2016;62(4):603–17. Epub 2016/05/18. doi: 10.1016/j.molcel.2016.04.028 . [DOI] [PubMed] [Google Scholar]
  • 74.Sharma E, Sterne-Weiler T, O’Hanlon D, Blencowe BJ. Global Mapping of Human RNA-RNA Interactions. Mol Cell. 2016;62(4):618–26. Epub 2016/05/18. doi: 10.1016/j.molcel.2016.04.030 . [DOI] [PubMed] [Google Scholar]
  • 75.Holley CL, Li MW, Scruggs BS, Matkovich SJ, Ory DS, Schaffer JE. Cytosolic accumulation of small nucleolar RNAs (snoRNAs) is dynamically regulated by NADPH oxidase. J Biol Chem. 2015;290(18):11741–8. Epub 2015/03/21. doi: 10.1074/jbc.M115.637413 ; PubMed Central PMCID: PMC4416874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Chen MS, Goswami PC, Laszlo A. Differential accumulation of U14 snoRNA and hsc70 mRNA in Chinese hamster cells after exposure to various stress conditions. Cell Stress Chaperones. 2002;7(1):65–72. Epub 2002/03/15. doi: ; PubMed Central PMCID: PMC514804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Mleczko AM, Machtel P, Walkowiak M, Wasilewska A, Pietras PJ, Bakowska-Zywicka K. Levels of sdRNAs in cytoplasm and their association with ribosomes are dependent upon stress conditions but independent from snoRNA expression. Sci Rep. 2019;9(1):18397. Epub 2019/12/06. doi: 10.1038/s41598-019-54924-2 ; PubMed Central PMCID: PMC6895083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Sloan KE, Warda AS, Sharma S, Entian KD, Lafontaine DLJ, Bohnsack MT. Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function. RNA Biol. 2017;14(9):1138–52. Epub 2016/12/03. doi: 10.1080/15476286.2016.1259781 ; PubMed Central PMCID: PMC5699541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Liberman N, O’Brown Z, Earl A, Boulias K, Gerashchenko M, Wang S, et al. N6-adenosine methylation of ribosomal RNA affects lipid oxidation and stress resistance. Science advances. 2020;6(17):eaaz4370. doi: 10.1126/sciadv.aaz4370 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Stiernagle T. Maintenance of C. elegans. WormBook. 2006:1–11. Epub 2007/12/01. doi: 10.1895/wormbook.1.101.1 ; PubMed Central PMCID: PMC4781397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Allen A, Nesmith J, Golden A. An RNAi-based suppressor screen identifies interactors of the Myt1 ortholog of Caenorhabditis elegans. G3 (Bethesda). 2014;4(12):2329–43. doi: 10.1534/g3.114.013649 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Rauthan M, Ranji P, Aguilera Pradenas N, Pitot C, Pilon M. The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway. Proceedings of the National Academy of Sciences. 2013;110(15):5981–6. doi: 10.1073/pnas.1218778110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 2003;421(6920):231–7. doi: 10.1038/nature01278 [DOI] [PubMed] [Google Scholar]
  • 84.Rual J-F, Ceron J, Koreth J, Hao T, Nicot A-S, Hirozane-Kishikawa T, et al. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome research. 2004;14(10b):2162–8. doi: 10.1101/gr.2505604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Nakamura S, Karalay Ö, Jäger P, Horikawa M, Klein C, Nakamura K, et al. Mondo complexes regulate TFEB via TOR inhibition to promote longevity in response to gonadal signals. Nature communications. 2016;7:10944. doi: 10.1038/ncomms10944 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Mathee K. Forensic investigation into the origin of Pseudomonas aeruginosa PA14—old but not lost. J Med Microbiol. 2018;67(8):1019–21. Epub 2018/08/02. doi: 10.1099/jmm.0.000778 . [DOI] [PubMed] [Google Scholar]
  • 87.Tjahjono E, Revtovich AV, Kirienko NV. Imaging and Fluorescence Quantification in Caenorhabditis elegans with Flow Vermimetry and Automated Microscopy. Bio-protocol. 2021;11(10):e4024. doi: 10.21769/BioProtoc.4024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Anderson QL, Revtovich AV, Kirienko NV. A High-throughput, High-content, Liquid-based C. elegans Pathosystem. Journal of visualized experiments: JoVE. 2018;(137). doi: 10.3791/58068 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Kirienko NV, Cezairliyan BO, Ausubel FM, Powell JR. Pseudomonas aeruginosa PA14 pathogenesis in Caenorhabditis elegans. Methods Mol Biol. 2014;1149:653–69. doi: 10.1007/978-1-4939-0473-0_50 [DOI] [PubMed] [Google Scholar]
  • 90.Schneider C, Rasband W, Eliceiri K. NIH Image to ImageJ: 25 years of image analysis. Nature methods. 2012;9(7):671–5. doi: 10.1038/nmeth.2089 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Braeckman B, Houthoofd K, De Vreese A, Vanfleteren J. Assaying metabolic activity in ageing Caenorhabditis elegans. Mechanisms of ageing and development. 2002;123(2–3):105–19. doi: 10.1016/s0047-6374(01)00331-1 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Gregory P Copenhaver, Javier E Irazoqui

8 Nov 2021

Dear Dr Kirienko,

Thank you very much for submitting your Research Article entitled 'Box C/D Small Nucleolar Ribonucleoproteins Regulate Mitochondrial Surveillance and Innate Immunity' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Javier E. Irazoqui

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The manuscript by Tjahjono, Revtovich, and Kirienko describe a new role for the box C/D small nucleolar ribonucleoproteins in regulating mitochondrial recovery and innate immunity. The authors wished to identify new regulators of the ESRE network, a mitochondrial surveillance pathway that comprises genes whose promoters contain the ESRE motif. Using a biochemical pulldown approach involving a tandem ESRE motif repeat oligonucleotide, the authors identified the box C/D snoRNP complex members FIB-1 and NOL-56, as regulators of the ESRE pathway. In addition, box C/D snoRNPs also regulated other mitochondrial surveillance pathways including the UPRmt and MAPKmt. The spatial requirement of the snoRNP in regulating these mitochondrial surveillance pathways was also examined using RNAi against ruvb-1, a component required for assembly and localization of box C/D snoRNP to the nucleoli. Nucleolar localization of snoRNP was required for ESRE regulation but only partially for the MAPKmt pathway and was not required for the UPRmt. The authors also confirmed that members of the H/ACA snoRNP complex do not have a role in mitochondrial surveillance and furthermore, that defects in translation are unlikely the cause for the effects observed with box C/D snoRNP knockdown. Lastly, using previously established reporters, the authors find that box C/D snoRNP functions to repress the innate immune response. Consistent with this finding, knockdown of members of the box C/D snoRNP increases host survival during infection with P. aeruginosa under slow-killing conditions in which the host succumbs to pathogen colonization. However, loss of box C/D snoRNP members rendered animals more sensitive to P. aeruginosa under liquid-killing conditions, which kills the host via iron sequestration from mitochondria.

The manuscript is overall a well-written body of work and the identification of the box C/D snoRNP complex as a regulator of mitochondrial surveillance and host immunity is novel and will be of interest to those studying cellular stress response pathways and host-pathogen interactions. However, the following suggestions could help improve the author’s findings.

Major revisions

The authors’ model suggests that box C/D snoRNPs encourage mitochondrial surveillance pathways by suppressing the immune response which can be quite energy-consuming. However, these conclusions are based on a handful of specific gene transcriptional GFP reporters and limited survival/lifespan assays. I would suggest the following to make their model more substantive.

1. The authors suggest that loss of box C/D snoRNPs reduces mitochondrial recovery, a finding that is based on altered activity of mitochondrial surveillance reporters. The authors should assay mitochondrial functions in the absence of box C/D snoRNPs such as mitochondrial membrane potential and/or oxygen consumption rates.

2. It is intriguing that loss of fib-1, but not other box C/D snoRNP complex members, results in increased lifespan (Figure 1E) since mitochondrial surveillance is predicted to be compromised in this animal. Mitochondrial stress is a known inducer of increased longevity, as observed with mitochondrial mutants clk-1, isp-1, nuo-6 or cco-1 RNAi, among others. The UPRmt and MAPKmt are also required for the extended lifespan of some of these conditions. It would be interesting to measure the lifespan for some of these long-lived mitochondrial stressed animals in the presence or absence of FIB-1. If FIB-1 is truly promoting mitochondrial surveillance, then the increased lifespan of fib-1 RNAi animals should not be additive with the increased lifespan of these mitochondrial stressed animals. Instead, fib-1 RNAi should reduce the lifespans of these animals (possibly to levels observed with fib-1 RNAi alone) based on the authors’ model, due to their compromised mitochondrial surveillance ability.

3. Related to comment 2) the authors did not observe increased lifespan in the absence of nol-56/58. Is this a consequence of stronger RNAi knockdown of these genes compared to fib-1 RNAi? If nol-56/58 RNAi were to be diluted, would they observe an increase in lifespan or is this effect specific to fib-1 RNAi?

4. a) The author’s model proposes that the box C/D snoRNPs repress immunity to favor mitochondrial surveillance. They show that two immune reporters, irg-1::GFP and irg-5::GFP are induced with box C/D snoRNP RNAi. Ideally, a more global view of transcriptional changes occurring in the presence or absence of box C/D snoRNP using RNAseq would provide more support for their model. Alternatively, one could test by qPCR a set of immune genes that are known to be regulated by mitochondrial surveillance programs (e.g. Campos et al. 2021 PMID 34617666, Pellegrino et al. 2014; PMID 25274306) in the presence or absence of box C/D snoRNPs.

b) Also, pathogen gut colonization should be tested to complement their slow-killing survival assay and to further support their model that immune responses and host resistance are enhanced with loss of box C/D snoRNP.

5. The authors find that transcriptional induction of immune genes following loss of box C/D snoRNP is partially or fully dependent on PMK-1/p38 and ATF-7/ATF7. The authors should perform their slow-killing survival assays in the presence or absence of PMK-1/ATF-7 to support their gene expression data.

Also, is ZIP-2 implicated in the increased survival of box C/D snoRNP deficient animals? This seems relevant since irg-1 was induced in the absence of box C/D snoRNP and ZIP-2 is a critical regulator of this gene during P. aeruginosa infection and with translation repression. As well, the authors previously determined ZIP-2 to be related to ESRE gene expression regulation.

Minor revisions

1. lines 201-208: The authors should speculate why the localization of box C/D snoRNPs is relevant for the regulation of some, but not all, of the mitochondrial surveillance pathways.

2. lines 214-16: The authors should comment further on their finding of increased FIB-1::eGFP punctae size with rotenone. What is the significance of this effect? Also, is the increased size of FIB-1::eGFP punctae specific for rotenone treatment? Do other mitochondrial stress conditions that activate the UPRmt/MAPKmt have a similar effect? Do they also observe increase puncta size during infection with P. aeruginosa slow-killing/liquid killing conditions?

3. More details on statistical analysis for lifespan and survival assays are needed. A supplementary table listing all survival/lifespan replicates should be provided. Included in this table should be the number of animals censored for their experiments. Also, statistical comparisons for these assays should follow the guidelines found in Petrascheck and Miller (2017); PMID 28713422.

4. The authors should provide more details in the figure legends of the color codes used for their statistical comparisons and what they signify.

5. Figure 2C: the pictures of tbb-6::GFP in the absence of stress do not obviously reflect the increase in expression that is reported in the quantification graph for fib-1, nol-56, and nol-58 RNAi. Perhaps a higher exposure would allow a better distinction between treatments?

6. Typo on line 160: “we triggered activation of the of downstream effectors for”. Remove “of”.

7. Typo on line 292-3: “its known regulation by the ATF-7/ATF7” should read “its known regulation by the transcription factor ATF-7/ATF7”.

Reviewer #2: Mitochondrial surveillance is crucial for maintaining organismal health under various stress conditions, including pathogen infections. In this manuscript entitled “Box C/D Small Nucleolar Ribonucleoproteins Regulate Mitochondrial Surveillance and Innate Immunity”, the authors reported novel functions of the box C/D snoRNA core proteins (snoRNPs) in upregulating mitochondrial surveillance and modulating immune responses. The authors previously reported the roles of Ethanol and Stress Response (ESRE) pathway and ESRE motif in mitochondrial surveillance in response to intracellular stressors. In the current work, the authors found that the box C/D snRNP component proteins, including FIB-1, NOL-56, and NOL-58, upregulated the ESRE pathway and mitochondrial unfolded protein response (UPRmt) under mitochondrial stress conditions. The authors identified the box C/D snRNP component proteins from ESRE motif-binding proteins by using pulldown and mass spec analysis. They showed that knockdown of the box C/D snRNP component proteins upregulated MAPKmt stress pathways. In addition, knocking down the box C/D snoRNP components upregulated immune effectors and altered the resistance of C. elegans against pathogenic bacteria. Overall, the authors suggested that box C/D snoRNPs act as molecular switch between mitochondrial surveillance and innate immunity through ESRE and MAPKmt signaling pathways. This paper starts with the unbiased biochemical identification for ESRE-regulating factors in combination with RNAi screen, and ends with molecular genetic analysis for functional importance of the the box C/D snRNP for immunity. This work is thorough and novel, and will provide valuable information regarding the research field of mitochondrial biology and immunity. I have basically one major concern in addition to minor ones that will further improve the quality of this excellent paper.

Major comments

1. The genetics in this paper solely depends on RNAi knockdown. RNAi experiments are variable and less reliable than those with mutants, in particular when the data are negative and double RNAi is used. I strongly recommend that the authors strengthen some of the data by performing additional experiments and also by discussing the caveat of using RNAi in the Discussion. Following are my specific suggestions.

1.1. Double RNAi experiments in Figures 2 and 3. The authors performed double RNAi experiments using RNAi-expressing bacteria mixture. They need to show the efficiency of RNAi for the experiments using qRT-PCR (or less preferentially fluorescence reporters) to rule out the possibility that RNAi clones work less efficiently.

1.2. Negative data with RNAi in Figures 4, S4 and S7. Here we don’t know whether RNAi simply did not work or work less efficiently for these experiments. The authors again need to perform qRT-PCR or reporter assays.

1.3. Additional experiments with pmk-1 and atf-7 mutants for Figures 5 and 6. As the mutants are available for pmk-1 and atf-7, and some of the data are the key data, I think they need to test whether the partial and complete requirement of pmk-1 and atf-7 are caused by hypomorphic nature or RNAi.

1.4. Discussion for the limitation of RNAi. Validating RNAi data with the above experiments will dramatically improve the quality of the paper, but practically I also understand that it will require enormous time and efforts. I think the authors may perform some key experiments for validation of RNAi and discuss the limitation of remaining data in the Discussion.

Minor comments

1. The authors showed the quantification data of GFP fluorescence with representative fluorescent images in Figures 1 and 2. However, they did not display fluorescent images for Figures 3 to 6. It will be better to show fluorescent images of following strains that are not shown in Figures 1 and 2: Phsp-6::GFP reporter strains that were crossed with Patfs-1ΔESRE::ATFS-1WT in Figure 3A or Pirg-5::GFP reporter treated with fib-1, nol-56, or nol-58 RNAi in Figure 5.

2. The central part of the Abstract should be re-written with a little more details to deliver the main results of this paper better.

3. The authors explained three mitochondrial surveillance pathways based on previous studies with various organisms. Those organisms need to be specified in the Introduction.

4. On page 6, the authors identified regulatory components of the ESRE pathway by using pulldown assays. It will be better for the authors to add a Supplemental table for listing up those 75 candidates that were identified.

5. In Figure legends, please explain specific information regarding the data with more details. For example, the authors did not explain the meaning of the colors of in the bar graphs for statistical significance at the beginning, although they explained this on page 9.

6. On page 9, in figure 3, they may want to move Figure S1B to Figure 3B for better comparison between the effects of RNAi starting at L3 and starting at L1.

7. Bar graphs in the Figures will be better to be changed with dot plots. That is a standard these days.

8. On page 12, figure 5, the authors showed the expression of Pirg-1::GFP and Pirg-5::GFP reporters to show the effects of Box C/D snoRNPs on innate immune responses. It will be more convincing if the authors show more targets for further verification, using additional reporters or by performing quantitative RT-PCR.

9. On page 14, the authors mentioned that RNAi targeting box C/D snoRNP components reduced the survival of worms in liquid-based pathogen killing assay, whereas the knockdown increased survival of worms in slow killing assay on agar plates. The authors need to elaborate the conclusion and add discussion for these seemingly contradicting data. The authors also need to change the subheading of this paragraph because it is confusing with respect to the main point of this paper mentioned in the Abstract.

10. In Discussion section, the authors suggested a hypothesis that modification on rRNA by box C/D snoRNP may facilitate translation of specific sub-population of transcripts. A previous paper (Liberman et al., 2020, Science advances; DOI: 10.1126/sciadv.aaz4370) reported that ribosome methylation can facilitate selective translation. I suggest the authors cite this paper in the Discussion section to support the hypothesis.

11. As they mentioned in the Introduction, many papers including Pellegrino et al. 2014, Nature; Kirienko et al. 2015, PNAS; Jeong et al. 2017, EMBO J; Deng et al. 2019, PNAS; Campos et al., 2021 EMBO Rep. have shown that mitochondrial surveillance pathways such as UPRMT activates innate immune responses in C. elegans. They need to cite missing literature and discuss the effects of snoRNPs on protective roles of mitochondrial surveillance systems upon pathogen exposure.

12. For describing Figure 1E, Tiku et al. 2017 needs to be cited and mentioned, because they reported that fib-1 RNAi extends lifespan.

13. Please unify the units (e.g. use ‘hours’ instead of ‘h’ in the method section).

14. Please explain each abbreviation in Figure legends and Methods (on page 22, e.g. SK).

Reviewer #3: This works examines the very interesting but complex interactions among various mitochondrial surveillance pathways including mtUPR, MAPK, and ethanol and stress response network (ESRE) in C. elegans. Here, the authors seek to unravel the transcriptional regulation of the ESRE network and understand the various interacting pathways. Through biochemical mass spec screens, the authors find surprisingly that components of Box C/D SnoRNA methylation complex physically associate with an 11 bp DNA motif comprising the ESRE element. This is unexpected because Box C/D SnoRNA complex is mainly involved in the processing rRNA. Consistent with a regulatory role, knockdown of these components dampens the induction of an ESRE element reporter, and correspondingly the mtUPR reporter hsp-6, but not the mito mapk reporter tbb-6, suggesting specific interaction. In line with specificity, knockdown of the HACA SnoRNA pseudouridylation complex has no such effects. Nor is it simply due to reduced translation, since kd of translational regulators does not inhibit ESRE induction. Further the authors find that knockdown of C/D SNO complex triggers expression of innate immune signaling genes in a manner dependent on the atf-7 transcription factor. Corresponding, worms are protected in slow killing, but not fast killing assays of P. aeruginosa.

This paper represents a conceptual advance as it suggests potential tradeoffs between mitochondrial surveillance and innate immune response, but there are several technical deficiencies that need to be addressed.

1. There is little mechanistic insight into how fibrillarin and nol-56 regulates the ESRE site either directly or indirectly, though the authors remark extensively on this in the discussion. Are the authors suggesting that fib-1 or nol-56 directly bind directly to the ESRE element and act in transcriptional regulation? Or is this a non-specific effect of an abundant protein binding to nucleic acid? To address this, they should also compare wt and mutated ESRE site with worm extracts. Notably, the gel shift in Figure 1 is not publication quality.

2. Reporter constructs can be misleading, particularly if they are multicopy arrays. Can the authors confirm that kd of Box C/D components regulates expression at the level of mRNA of a number of ESRE element containing inducible genes?

3. It has been previously shown that knockdown of nucleolar proteins (fib-1, and nol-6) result in enhanced pathogen resistance, so the connection innate immunity to nucleolar function aspect is not entirely novel. However, extending these observations to the whole C/D SnoRNA complex is interesting, and appears specific since similar physiology is not seen with HACA SnoRNA and pseudouridylation. The question is whether this contrast reflects a difference in the degree of RNAi knockdown, however, and thus levels of transcripts should be quantitated by RT-PCR.

4. Opposite to Box C/D knockdown, the authors nicely show that kd of a number of translational regulators still support activation of the ESRE reporter. Is this also true of small and large subunits of the cytosolic ribosome?

5. A major technical problem could arise from the use of double RNAi. Double RNAi often causes mutual hindrance of the knockdown, and could thus appear as suppression. Empty vector control is not the best one. Instead the authors should use luciferase RNAi, in which the RNAi machinery is induced, but is absent a target, in order to validate their findings in at least a few critical experiments.

6. Figure 3 is confusing and not adequately explained. The authors delete the ESRE element from the ATFS-1 promoter and claim that it has lower levels of hsp-6 expression upon rotenone exposure. Is this a crispr deletion in the chromosome? Judging from the methods it looks like a transgenic insertion. What is it compared to? A wt multicopy array? How can the authors really compare a wt multi copy array to a mutant one without knowing copy number?

7. Overall the paper suggests that snoRNPs are required for activation of mitochondrial stress response ESRE as well as UPRmt, but snoRNP complex was not required for activation of MAPKmt response. Therefore, I don’t understand the model, as it shows UPRmt suppresses MAPKmt (after stress), yet spg-7 RNAi activates both UPRmt as well as MAPKmt, so there should be an activation arrow rather than suppression. Further, there is a clear requirement of snoRNP for UPRmt activation, but it has no effect at all on MAPKmt activation, again not justified by their model.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: No: The list of the identified proteins from their mass spec analysis should be provided as a supplemental table.

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Seung-Jae V. Lee

Reviewer #3: No

Decision Letter 1

Gregory P Copenhaver, Javier E Irazoqui

14 Feb 2022

Dear Dr Kirienko,

We are pleased to inform you that your manuscript entitled "Box C/D Small Nucleolar Ribonucleoproteins Regulate Mitochondrial Surveillance and Innate Immunity" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Javier E. Irazoqui

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have sufficiently addressed my concerns. I recommend accepting the current version of the manuscript.

Reviewer #2: The authors addressed all my concerns successfully and the paper has been greatly improved.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Seung-Jae V. Lee

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-01267R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory P Copenhaver, Javier E Irazoqui

8 Mar 2022

PGENETICS-D-21-01267R1

Box C/D Small Nucleolar Ribonucleoproteins Regulate Mitochondrial Surveillance and Innate Immunity

Dear Dr Kirienko,

We are pleased to inform you that your manuscript entitled "Box C/D Small Nucleolar Ribonucleoproteins Regulate Mitochondrial Surveillance and Innate Immunity" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Katalin Szabo

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Proteomic assays revealed the presence of ESRE-binding factor(s).

    Electrophoretic mobility shift assay (EMSA) showed the presence of the ESRE-binding motif through the identified ‘Shift’. Worms were treated with DMSO or 50 μM rotenone for 14 hours. D: DMSO-treated, R: rotenone-treated, 4xESRE: oligo bait, and 4xESRE(M): oligo bait with mutations.

    (TIFF)

    S2 Fig. The use of RNAi targeting luciferase yielded in similar results of multiple reporters’ expressions as compared to empty vector control in both single and double RNAi settings.

    (A) Quantification of GFP fluorescence of C. elegans carrying 3XESRE::GFP that were reared on E. coli expressing RNAi targeting empty vector (EV) or luciferase. Worms were treated for 8 hours with vehicle (DMSO) or 25 μM rotenone. RNAi was started at L1 (left) or L3 stage (right). (B) Quantification of GFP fluorescence of C. elegans carrying Phsp-6::GFP (top) and Ptbb-6::GFP (bottom) reporters that were reared on E. coli expressing RNAi targeting empty vector (EV) or luciferase. Double RNAi was performed with empty vector (EV) or luciferase, or spg-7(RNAi). Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from Student’s t-test. GFP values were normalized to EV-DMSO or EV. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In (A), purple significance marks indicate comparison of luciferase(RNAi) to EV(RNAi) in DMSO, red marks indicate comparison of luciferase(RNAi) to EV(RNAi) in rotenone, and black marks indicate comparison between expressions in rotenone and DMSO. In (B), red significance marks indicate comparison between luciferase(RNAi) to the corresponding condition but with EV(RNAi), e.g., fib-1;luciferase(RNAi) vs. fib-1;EV(RNAi) and spg-7;luciferase(RNAi) vs spg-7;EV(RNAi).

    (TIF)

    S3 Fig. Knockdown of box C/D snoRNP assembly factor RUVB-1 slightly affected mitochondrial surveillance pathways.

    Quantification of GFP fluorescence of C. elegans carrying (A) 3XESRE::GFP, (B) Phsp-6::GFP, and (C) Ptbb-6::GFP reporters that were reared on E. coli expressing RNAi targeting empty vector (EV) or ruvb-1/RUVB. In (A), worms were treated for 8 hours with vehicle (DMSO) or 50 μM rotenone. In (B, C), double RNAi was performed with empty vector (EV) or spg-7(RNAi). (D) Images and fluorescence intensity quantification of C. elegans carrying Pfib-1::FIB-1::eGFP reporter that were reared on E. coli expressing RNAi targeting empty vector (EV), fib-1/FBL, or ruvb-1/RUVB. RNAi was started at L1 or L3 stage as indicated in the figure. Three biological replicates with (A-C) ~400 worms/replicate or (D) ~25 worms/replicate were analyzed. p-values were determined from Student’s t-test. GFP values were normalized to EV-DMSO or EV. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In (A-C), purple significance marks indicate comparison of ruvb-1(RNAi) to EV(RNAi) in unstressed condition (DMSO or EV(RNAi)), red marks indicate comparison of ruvb-1(RNAi) to EV(RNAi) in stressed condition (rotenone or spg-7(RNAi)), and black marks indicate comparison between stressed and unstressed conditions.

    (TIFF)

    S4 Fig. RNAi targeting core members of box H/ACA snoRNPs did not affect mitochondrial surveillance pathways.

    Quantification of GFP fluorescence of C. elegans carrying (A) 3XESRE::GFP, (B) Phsp-6::GFP, or (C) Ptbb-6::GFP reporters that were reared on E. coli expressing empty vector (EV) or RNAi targeting box H/ACA snoRNP members: nola-3/Nop10, Y48A6B.3/Nhp2, or Y66H1A.4/Gar1. In (A), worms were treated for 8 hours with vehicle (DMSO) or 50 μM rotenone. In (B, C), double RNAi was performed with empty vector (EV) or spg-7(RNAi). Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from two-way ANOVA, followed by Dunnett’s test, and Student’s t-test. All fold changes were normalized to DMSO-EV or EV control. NS not significant, *p < 0.05, ** p < 0.01, *** p < 0.001. In all panels, purple significance marks indicate comparison of H/ACA genes(RNAi) to EV(RNAi) in unstressed condition (DMSO or EV(RNAi)), red marks indicate comparison of H/ACA genes(RNAi) to EV(RNAi) in stressed condition (rotenone or spg-7(RNAi)), and black marks indicate comparison between stressed and unstressed conditions.

    (TIF)

    S5 Fig. Quantitative RT-PCR verified reduction of transcripts in RNAi targeting members of box H/ACA and eukaryotic 48S transcription initiation complex.

    mRNA levels of target genes in N2 worms reared on E. coli expressing RNAi targeting Y48A6B.3, clu-1/eIF3A, ife-2/ eIF4E, or inf-1/eIF4A. Three biological replicates with ~8,000 worms/replicate were analyzed. All fold changes were normalized to expression of target genes in worms reared on EV(RNAi)-expressing E. coli.

    (TIF)

    S6 Fig. Knockdown of box C/D snoRNPs induced immune response gene irg-1.

    (A, B) Quantification of GFP fluorescence of C. elegans carrying Pirg-1::GFP reporter that (A) were reared on E. coli expressing empty vector (EV), fib-1(RNAi), nol-56(RNAi), or nol-58(RNAi) or (B) exposed to 2 mg/mL cycloheximide or DMSO control for 8 hours. Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from (A) one-way ANOVA, followed by Dunnett’s test or (B) Student’s t-test. All fold changes were normalized to EV or DMSO control. *p < 0.05, ** p < 0.01.

    (TIF)

    S7 Fig. Cycloheximide treatment did not affect mitochondrial surveillance pathways.

    Quantification of GFP fluorescence of C. elegans carrying (A) 3XESRE::GFP or (B) Ptbb-6::GFP reporters that were treated for 8 hours with vehicle (DMSO) or 2 mg/mL of translation elongation inhibitor cycloheximide. Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from Student’s t-test. NS not significant.

    (TIF)

    S8 Fig. RNAi targeting core members of box H/ACA snoRNPs did not affect innate immune pathways.

    Quantification of GFP fluorescence of C. elegans carrying (A) Pirg-1::GFP or (B) Pirg-5::GFP reporters that were reared on E. coli expressing empty vector (EV) or RNAi targeting box H/ACA snoRNP members: nola-3/Nop10, Y48A6B.3/Nhp2, or Y66H1A.4/Gar1. Three biological replicates with ~400 worms/replicate were analyzed. p-values were determined from one-way ANOVA, followed by Dunnett’s test. All fold changes were normalized to EV control. NS not significant.

    (TIF)

    S9 Fig. RNAi targeting box C/D snoRNPs provides protection in atf-7(gk715) and pmk-1(km25) mutants in agar pathogenesis model.

    (A, B) Survival of N2 wild-type, atf-7(gk715), or pmk-1(km25) mutants reared on RNAi strains targeting empty vector (EV) and (A) nol-56 or (B) nol-58. Three biological replicates with ~150 worms/replicate were analyzed. Representative replicates are shown. p-values were determined from log-rank test. *** p < 0.001. Purple significance marks indicate comparison of atf-7(gk715) or pmk-1(km25) mutants to N2 wild-type (reared on EV(RNAi)), red marks indicate comparison of atf-7(gk715) or pmk-1(km25) mutants to N2 wild-type (reared on nol-56(RNAi) or nol-58(RNAi)), and black marks indicate comparison between nol-56(RNAi) or nol-58(RNAi) vs. EV(RNAi) for each worm strain.

    (TIF)

    S1 Table. List of 75 protein candidates obtained from mass spectrometry.

    (XLSX)

    S2 Table. Raw data of lifespan measurement of glp-4(bn2) worms.

    Animals were reared on RNAi targeting box C/D snoRNPs or empty vector control. Raw data of 3 replicates were shown.

    (XLSX)

    S3 Table. Raw data of survival of glp-4(bn2) worms under Slow Killing assay.

    Animals were reared on RNAi targeting box C/D snoRNPs or empty vector control. Raw data of 3 replicates were shown.

    (XLSX)

    S4 Table. Raw data of survival of N2 wild-type and atf-7(gk715) and pmk-1(km25) mutants under Slow Killing assay.

    Worms were reared on RNAi targeting box C/D snoRNPs or empty vector control. Raw data of 3 replicates were shown.

    (XLSX)

    S5 Table. Sequences of forward and reverse primers for quantitative RT-PCR experiments used in this study.

    (XLSX)

    S1 Data. Numerical data underlying all graphs.

    (XLSX)

    Attachment

    Submitted filename: Tjahjono et al Author Response.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES